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ABSTRACT 
 
 
 Canadian cancer clinics are straining to keep up with growing numbers of patients 
and, as a result, the capacity to provide follow-up care to cancer patients is being stretched. 
The Saskatchewan Cancer Agency has structured its community follow-up program to 
ensure the routine follow-up of patients who have finished active cancer treatments. 
Follow-up letters are routinely sent to family physicians and some specialists requesting 
information on the disease status of their cancer patients. For this thesis, I conducted a mail 
survey of 925 Saskatchewan physicians serving 21,000 patients to learn about general 
practitioners’ and specialists’ views of the follow-up program. A 52.5% response rate was 
achieved.  
 The program was considered useful for 91.5% of physicians, with the follow-up 
letter serving an important role in reminding physicians to see their cancer patients for 
follow-up. High percentages of physicians indicated a need for additional patient-specific 
information (59.3%), clinical information (73.0%) and training (34.9%) to do follow-up. 
Logistic regression analyses found female gender, a specialty in general practice and lower 
physician confidence in following cancer to be associated with the need for additional 
patient information. Lower physician confidence was associated with the need for 
additional clinical information and a specialty in general practice and lower physician 
confidence were associated with the need for more training. 
 Percentages of physicians saying they were very confident in following various 
cancers ranged widely from 19.1% for lymphomas to 54.2% for breast cancer. All 
regression models regarding physician confidence in following six different cancers had a 
common correlate: the need for additional training. A physician’s number of follow-up 
patients was a significant correlate in four of the six regression models and physician 
specialty was included in half of the models. 
 The results suggest areas of the program and physician need that should be 
addressed to ensure the delivery of quality follow-up care and the survey findings will be 
helpful in devising strategies to this end. At the same time, responses indicate the program 
to be an essential component in the delivery of community-based follow-up care in 
Saskatchewan.  
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CHAPTER 1 
 
INTRODUCTION 
 
 
1.1 General Background and Statement of the Problem 
 The purpose of follow-up cancer care is to detect local and distant recurrences, 
identify second primary cancers, provide psychosocial support to patients and their 
families and collect data on patient outcomes.1, 2 As early detection programs improve, the 
occurrence of various cancers increases, and better treatments increase survival rates, the 
demand for follow-up care will continue to increase.3, 4 A major concern is that the demand 
for follow-up care will constrain the time available for cancer patients with active disease 
who need the attention of cancer specialists more immediately.5  
 The Saskatchewan Cancer Agency’s Follow-By-Mail program (FBM) originated as 
a method of tracking patient survival data for the provincial Cancer Registry as well as for 
identifying episodes of recurrence or metastases. Although FBM is still used as a method 
of survival/recurrence analysis, it has also become a method to routinely follow patients 
through their general practitioners (GPs), surgeons or other specialists in an effort to 
mitigate high patient volumes at the province’s cancer centres. The program is meant to 
encourage proper follow-up care for patients discharged from or not attending one of the 
province’s cancer centres. An additional advantage of FBM is that the travel burden 
experienced by many patients is decreased by providing care in their own communities. 
The overall aim of the program is to increase survival and enhance patients’ quality of life. 
The precursor program to FBM began operating in 1932, but neither of the programs had 
been formally evaluated. 
1.2 Purpose of the Study 
 The purpose of this evaluation was to determine physicians’ views of FBM. Of 
primary importance was gaining an understanding of the extent to which physicians’ 
 1
information needs are being met by the program and to evaluate physicians’ levels of 
confidence in providing follow-up care with the assistance of FBM.  
1.3 Significance of the Study 
 As part of the accreditation process for the SCA, FBM was identified as a program 
that should be evaluated as the program is unique in Canada. The study was meant to assist 
the SCA in identifying aspects of the program needing improvement from the perspective 
of the community-based physician. The evaluation has the potential to assist in tailoring 
FBM to better meet the information and training needs of physicians and increase 
physicians’ confidence in doing follow-up. Optimizing the delivery of the program will 
enhance the provision of appropriate and consistent follow-up care across the province, 
thus freeing up appointments at the cancer clinics for patients with active disease and 
reducing the travel burden for patients who would otherwise need to travel long distances 
to receive follow-up care. The findings on physicians’ information and training needs as 
well as physician confidence could be used to encourage medical schools, medical 
associations and the SCA to help in addressing physicians’ unmet needs and suboptimal 
levels of physician confidence.  
 This study revealed to stakeholders whether or not physicians think the program is 
worthwhile. As a result, the findings have already impacted funding decisions. The 
findings on program usefulness may also be used to encourage other provinces and 
territories to implement a program like FBM to facilitate the delivery of follow-up care in 
their jurisdictions. Community-based cancer follow-up outside of Saskatchewan is 
currently left up to patients and their regular physicians to keep track of appropriate 
intervals for follow-up. 
1.4 Program Description 
 Patients are generally placed on FBM either at the time of discharge from a cancer 
clinic or, for patients not seen at a cancer clinic, upon registration with the provincial 
Cancer Registry. Four groups of patients are enrolled in the program: 1) those who have 
finished active treatments and follow-up at a cancer clinic, 2) some palliative (those with 
terminal illnesses) patients, 3) those who have had surgery and have not been seen at a 
cancer clinic and 4) those who have to wait a considerable time for their next appointment 
at a cancer clinic. Upon enrolment, FBM letters are sent to the patient’s GP, surgeon or 
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other specialist along with recommended follow-up guidelines on the back of the letter. 
There are site-specific letters for breast, colorectal, lung, prostate, endometrial, cervical 
and ovarian cancers and Hodgkins/non-Hodgkins lymphoma. Generic letters without 
guidelines are used for other cancers. A letter may be sent directly to a patient when it is no 
longer deemed necessary to follow that individual through a physician. The intent of this 
follow-up is to verify the patient’s status, current physician and contact information. A 
letter may also be sent to an out-of-province cancer clinic if a patient is being followed 
there. The follow-up letters are generated automatically at intervals dependent on the type 
of cancer, how long the patient has been enrolled in FBM and whether or not the patient is 
disease-free. Intervals range from four months to two years. After the first two to three 
years of follow-up, disease-free patients are normally followed annually for a total follow-
up period of ten years.  
 Each completed and returned FBM letter is coded into an electronic system. The 
patient’s disease status, information on recurrence or metastasis and any treatment-related 
information are entered. If a letter contains comments from the signing physician, the letter 
may be referred to an oncologist for review. At that time, the interval for sending FBM 
letters may be adjusted. 
 Approximately 1,000 letters are sent out per month from each of the province’s two 
cancer clinics. The return rate on these letters is approximately 98%. The program serves 
21,000 patients with follow-up care provided by about 1,000 physicians.  
1.5 Evaluation Framework 
 This study was primarily a process evaluation that took a utilization-focused 
approach. Process evaluations answer questions about the effectiveness of program 
operations and implementation, rather than making judgments about the overall 
effectiveness, merit or worth of a program.6, 7 They investigate how well the program is 
functioning.6 Such evaluations provide information for quality assurance purposes in that 
they assess the degree to which a program is implemented as intended and is operating at 
an acceptable level.6 Also called formative evaluations, process evaluations indicate areas 
requiring improvement.6 
 This evaluation describes how well FBM is operating from the perspective of the 
community-based physicians providing follow-up cancer care. As important stakeholders 
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and frontline care providers, their views of the program offer unique perspectives and 
insights into the functioning of the program. Such feedback will be and has been useful in 
enhancing the program’s role in the delivery of optimal patient care. 
 Patton describes program evaluation as “the systematic collection of information 
about the activities, characteristics, and outcomes of programs to make judgments about 
the program, improve program effectiveness, and/or form decisions about future 
programming.”7 He goes on to define utilization-focused evaluation (UFE) as “evaluation 
done for and with specific, intended primary users for specific, intended uses.”7 UFE is a 
comprehensive approach to evaluation which aims to increase the likelihood that 
evaluation findings will be used and acted upon.  
 The starting point for UFE is the belief that judgment about an evaluation should be 
based on its utility and actual use; therefore, the evaluator facilitates the planning and 
implementation of an evaluation with consistent attention to how use will be affected.7 
This pragmatic approach gives the evaluator flexibility to use any type of research design 
that is “relevant, rigorous, understandable, and able to produce useful results that are valid, 
reliable, and believable.”7 
 Patton reports that after studying a number of possible factors which could 
influence use, two factors consistently emerged as important—one factor being political 
considerations and the other what he calls the ‘personal factor.’ Since evaluations judge 
merit or worth, they are always political. For example, program personnel may have 
different opinions about why the evaluation is being done and if the program should be 
evaluated at all. Others may wonder if the evaluation will have any impact and if the 
results will be reflective of the actual circumstances of the program. The evaluator must be 
aware of the political context in which the program is situated so that the evaluation is 
influential. The personal factor is described as “the presence of an identifiable individual or 
group of people who personally care about the evaluation and the findings it generates.”7 It 
is for this reason that the primary intended users of the evaluation, those who were actively 
seeking information to make judgments about FBM, were sought out at the beginning of 
this evaluation. I then facilitated “judgment and decision making by intended users rather 
than acting as a distant, independent judge.”7  
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 UFE was influential in all stages of the evaluation. A number of activities were 
carried out to increase the likelihood that the evaluation results would be used, including: 
ongoing communication with key contacts at the SCA, solicitation of feedback from the 
SCA’s evaluation team when significant decisions had to be made, keeping the SCA’s 
executive director in the loop about the evaluation’s progress and discussions with the 
team regarding the evaluation’s intended influence on the program’s future and the 
standards by which survey results would be judged. These aspects of the evaluation are 
described in detail elsewhere. 
1.6 Research Questions 
 Based on the purposes of the evaluation as determined by the SCA evaluation 
committee (see Section 3.4), the following research questions were formulated: 
 
1. What are physicians’ overall impressions of FBM? 
 
2. Do FBM letters give physicians enough information to enable them to do cancer 
follow-up? 
 
3. How confident are physicians with providing follow-up care? 
 
 In the following chapter, the research literature related to these research questions 
is reviewed. 
 5
 
 
 
 
 
 
CHAPTER 2 
 
LITERATURE REVIEW 
 
 
 The literature presented in this chapter pertains to various aspects of cancer and 
cancer care relevant to FBM which had implications for the development of the research 
questions and interpretation of survey data.  
 
2.1      The Demand for Follow-up Care 
 The prevalence of cancer continues to rise as a result of Canada’s aging 
population.8 Cancer is most common among people over 50 and this group is projected to 
increase in size for many years to come.9,10 In addition, “more effective treatments are 
improving long-term survival and prolonging disease-free intervals; hence, more patients 
are defined as being in remission.”11 As a result, more and more patients are requiring 
follow-up care, putting a heavy burden on cancer centres in terms of budget and time 
resources.3 
 The number of new cancer cases in a population is an important measure of the 
burden of cancer on the health care system. Expected increases can be used to plan for the 
increasing demand on health services and the associated health care facilities.  
2.2 The Role of Cancer Centres in Canada 
 At cancer centres in Canada, specialists normally deliver multidisciplinary cancer 
treatments and team-based oncologic follow-up care as required.12 Once treatments are 
complete, patients are typically discharged back to their GPs or other referring 
physicians.12 GPs are often expected to provide ongoing primary care and cancer follow-
up.12  
 In terms of follow-up cancer care, FBM is unique in Canada. No other province or 
territory has a system through which community-based physicians are notified when it is 
 6
time to see a patient for follow-up. Routine linkages of cancer registries with vital statistics 
as a form of passive surveillance, however, are common practice.12 
2.3 Physicians’ Roles in Cancer Care outside the Cancer Clinic 
 Studies show that GPs want to be involved in the care of their patients who have 
cancer. One Canadian study found that family physicians wished to be more involved in all 
phases of cancer care.13 GPs have knowledge of patients and their families and this 
knowledge can be especially helpful in areas of care such as the provision of psychosocial 
support.13 One British study showed that 69% of GPs thought routine breast cancer follow-
up should be done by GPs.1 
 However, for various reasons, such as fear of missing a diagnosis of cancer 
recurrence and the perception that patients do not want to abandon their oncologists, some 
family physicians have reservations about doing follow-up.13 Some 9.9% of Canadian 
family physicians surveyed said they would not accept the responsibility of providing 
follow-up care for breast cancer patients.3 The majority (77.1%) of physicians, however, 
thought it was appropriate for family physicians to provide this type of care.3   
 Family physicians’ feelings of competence regarding the provision and 
coordination of care during remission vary, but physicians are more prepared to accept the 
responsibility of care if they are provided with practice guidelines to follow.13 Appropriate 
guidelines and support from cancer specialists are important to ensuring appropriate care.3 
Clinical practice guidelines are tools arising from the synthesis of the most up-to-date 
scientific knowledge and expert consensus.14 They are meant to eliminate gaps in 
practitioners’ knowledge, assist in informed decision-making, guide practitioners’ 
behaviour in an appropriate direction and improve the quality of care patients receive.15  
 Family physicians have the skills to do follow-up for most types of cancer.16 
Follow-up care generally involves history taking, physical examination, and sometimes 
blood tests and radiologic testing.16-18 Most (68.9%) British GPs believed they had the 
skills required for breast cancer follow-up, but 57.5% indicated they needed further 
training.19  
2.4 Communication between Physicians 
 Difficulties encountered by community-based physicians during follow-up may 
interfere with the delivery of such care. A family physician’s role in cancer care has been 
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described as that of support person, patient advocate, resource person, provider of general 
medical care, triage and referrals, member of the cancer team and team member with an ill-
defined role.3, 20-22 Family physicians have described numerous barriers in communicating 
with cancer specialists which hinder their roles in follow-up care. Extrinsic barriers, or 
those outside the control family physicians, include: follow-up by several physicians, 
delays in referrals, difficulty contacting cancer specialists, impersonal modes of 
communication (i.e., letters), lack of information about discharge and follow-up plans and 
trouble accessing information and knowledge about cancer.13, 20 Some intrinsic barriers to 
communication, or those within the control of family physicians, include: taking a passive 
approach, low self-esteem and self-image, fear of loss of specialist support, inadequate 
knowledge, fear of guilt or blame and varying needs of physicians and patients.20 
 Other studies have identified similar communication difficulties between 
physicians. Letters are the usual means by which physicians communicate with each 
other.23 The length of time it takes for the referring physician to receive a consultation 
letter from a cancer centre physician has been identified as a problem in numerous cases. 
Face-to-face or telephone contact are seen as more effective means of communication and 
may be important for negotiating the roles of the involved physicians.13, 20, 22 The lack of 
important details in reports regarding referred patients has also been a problem. 13, 23-25  
 In addition, family physicians are not commonly included in cancer care 
immediately following a diagnosis, making it difficult for them to become involved with 
the patient again after active treatment.17, 21, 26-28 Only 61.6% of surveyed primary care 
physicians in Alberta were actively involved in their patient’s care while they were being 
treated at a cancer centre.23 A lower percentage (30.8%) of FP involvement during the 
treatment phase of care was reported by cancer patients in Manitoba.21 
2.5 Physicians’ information needs 
 Physicians’ information needs are important to understand and address when 
administering a program that asks physicians to provide a particular type of patient care. 
The quality of information received from cancer specialists can have an impact on 
physicians’ knowledge about the patient’s disease and treatments and the physician’s 
satisfaction with the information.29 The quality of information sources such as peer review 
and validation has been shown to be important to physicians.30  
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 Johannson and her colleagues found that information provided by cancer specialists 
to GPs was generally insufficient.29 Accessibility to the right information in the most 
useful form is needed. Physicians require information that is particular to the questions 
asked and is applicable to clinical practice. 31 The needed information may be either 
general or patient-specific. 
 Keeping up with new developments in cancer care is not an easy task.32 For 
immediate decision-making by a physician at the point of care, information needs to be 
brief and easily interpreted.33 One study of primary care physicians found that physicians 
pursued answers in clinical practice to approximately 57% of their questions and found 
answers to about 70% of those questions they pursued.34 The UK’s National Health 
Service previously set a target time of fifteen seconds for a physician to find relevant 
guidance when a question arises at the time of patient consultation and two minutes while a 
physician is reflecting on a patient’s case.31 
 Various forms of patient-specific information are required for follow-up.  
In one study investigating the types of information GPs wanted from cancer specialists, the 
most important items were: information about the patient’s cancer and other diseases, 
future planning and the GP’s role in the care of the patient.29 Likewise, another study 
revealed that referring physicians wanted letters from medical oncologists to contain 
details about the patient’s diagnosis, clinical findings, test results, recommended future 
tests, treatment options, side effects and prognosis.35 
 A recent study in the UK found the most preferred information sources of family 
physicians to be their own personal collections, electronic sources and local specialists and 
colleagues.36 A US study showed primary care physicians preferred consultants, drug 
compendia, colleagues and textbooks. Similarly, physicians in one American state most 
frequently used personal or office collections of books and journals and consultation with 
colleagues.37 Family physicians have noted they would like access to information in 
written form, via the computer and internet and on a handheld device.30, 38 General 
surgeons have been found to prefer professional meetings, medical literature, MD 
colleagues, continuing education courses and personal libraries as their predominant 
information sources.39 The relevance of each of these information sources to Saskatchewan 
physicians providing follow-up cancer care is not currently known and the preferred 
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sources listed are likely to have been influenced by the rapid changes in the development 
of and access to electronic sources of information. 
  Physician characteristics such as specialty and gender should be considered when 
working to meet the information needs of physicians. Tattersall et al. found that more GPs 
than specialists expressed a desire to receive cancer diagnosis-related information 
including diagnosis, test results, clinical findings and explanation of symptoms.35 In 
another study, GPs tended to rate the importance of items on hospital discharge letters as 
more important than cancer specialists. Information about check-ups, diagnosis, current 
treatment and pain alleviation was highest ranking among GPs and specialists alike, 
whereas female GPs deemed psychosocial and caring items higher than both specialists 
and male GPs.25  
 Gruppen also found that many factors influenced the information sources used by 
physicians.40 These included: physician characteristics (e.g., age, experience and 
specialty), practice characteristics (e.g., community size, practice type and setting) and the 
availability of specialists, colleagues and educationally influential physicians or opinion 
leaders.40 Motivations for seeking information also vary. One study of family physicians 
found that physicians seek information because of needs resulting from both professional 
responsibilities and personal characteristics.36 Information seeking was predominantly 
intended to lead to problem-oriented information related to the care of individual patients, 
for keeping up-to-date and for finding information for patients.36 Other factors prompting 
GPs to seek information were the need for pharmacological information and specific gaps 
in knowledge on new diagnoses and therapies.36 
2.6 Summary 
 This review reveals a growing need for follow-up cancer care delivered by 
community-based physicians. Most GPs have expressed a desire to be involved in the care 
of their cancer patients and more physicians are willing to provide such care if they are 
provided with the needed information. Information may be patient-specific such as test 
results and side effects or more general in the form of clinical practice guidelines, for 
example. Physician characteristics may influence physicians’ information needs. The 
literature also identifies some barriers to the delivery of follow-up care including a lack of 
timely and pertinent information. This information was particularly useful in understanding 
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the nature and importance of follow-up care as well as survey results regarding physicians’ 
training needs and the importance of various information sources. 
 As this study investigated physicians’ confidence in following a number of cancers, 
I searched the literature for conceptualizations of this construct, but found none. There was 
also a gap in the literature regarding levels of unmet information needs among community-
based physicians delivering follow-up cancer care. 
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CHAPTER 3 
METHODOLOGY 
 
 
 A researcher-developed questionnaire was used in this study to explore physicians’ 
views on the Saskatchewan Cancer Agency’s Follow-By-Mail program, including their 
information needs and confidence in providing follow-up care. The following is a 
description of the study’s research methodology. A summary of the methods used can be 
found in Figure 3.1. 
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Figure 3.1: Summary of Study Methods 
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3.1. Setting 
 This study was conducted in the Canadian province of Saskatchewan which has a 
population of just under one million people.41 The province has a cancer centre in each of 
its two largest cities, Regina and Saskatoon. The direct costs of cancer care are covered by 
Saskatchewan’s publicly-funded health care system. FBM is the only program of its kind 
in Canada. 
3.2 Study Design 
 A cross-sectional design was used to address the research questions posed in 
Chapter 1. Cross-sectional survey designs allow researchers to assess aspects of a 
population at a single point in time. They assist in seeking explanations by examining the 
frequency of events and correlations between the variables of interest. Based on the study’s 
research questions, a cross-sectional survey design was chosen as the most appropriate 
method for assessing the physicians’ views on FBM. 
3.3 The Study Population 
 The population surveyed was comprised of physicians following cancer patients 
through FBM as listed in the SCA’s database on May 19, 2005, with the exception of those 
in the following specialties: psychiatry, anesthesiology, physical medicine, lab specialties 
and diagnostic radiology. These specialties were excluded as such physicians do not 
normally follow cancer patients. Physicians who took part in pre-testing the survey were 
also excluded. Those physicians in general or family practice and surgeons made up the 
population of surveyed physicians. The survey was sent to 987 physicians. This was 97.0% 
of all practitioners providing community-based follow-up care. 
3.4 Cancer Agency Evaluation Committee 
 The Saskatchewan Cancer Agency formed an evaluation committee to help direct 
the evaluation. The committee was comprised of two oncologists, two epidemiologists, 
two directors of health records and the director of the Saskatchewan Cancer Registry. The 
committee met as needed during the course of the evaluation. Two key contact persons 
from this committee assisted me in making logistical and day-to-day decisions regarding 
the project. Decisions regarding issues such as the focus of the evaluation, the content of 
the questionnaire and interpretation of the data were made at committee meetings or via 
email correspondence with committee members. 
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3.5 Intended Use of Evaluation Results 
 Helping intended users be intentional about the evaluation’s use through the 
project’s design phase can significantly increase the degree of influence the evaluation will 
have.7 As part of his utilization-focused approach, Patton recommends that evaluators ask 
intended users to be clear about the decisions the evaluation is expected to influence.7 As 
users articulate this type of information, the evaluator discovers their expectations, 
negotiates a shared understanding of use and helps form commitments to use.  
 Although the SCA evaluation committee exhibited a strong interest in the 
evaluation results from the start, I met with the evaluation committee to formally establish 
the evaluation’s intended use. A number of questions were discussed in the early planning 
stages of the project, including: 
• What are we hoping to accomplish? 
• What decisions, if any, are the evaluation findings expected to influence? 
• When will decisions be made? Is there any sense of urgency? Who will make 
the decisions? When must the evaluation findings be presented to be timely and 
influential? 
• What is at stake in the decisions? For whom? Are there any controversies or 
issues surrounding the decisions? 
• How much influence do you expect the evaluation to have?7 
 
 The committee’s responses to these questions helped focus the evaluation. This 
process also facilitated the group in anticipating some of the sensitivities around the results 
and what might be done in response to less than optimal results.  
3.6 Instrument Design 
 The development of the survey instrument involved a number of steps including the 
elucidation of the program’s theory of action (program logic model), key informant 
interviews, input from the evaluation committee and survey pre-testing. The following 
describes the process of questionnaire design.  
 3.6.1 Program Logic Model 
 A preliminary step in the design phase of this study was to elucidate FBM’s 
underlying program theory or theory of action. Program theory has been defined as “the 
construction of a plausible and sensible model of how a program is supposed to work.”42 
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The process of describing program theory involves the identification of “all the important 
program functions that must be performed for the program to operate as intended.”6 Due to 
the complexity of the types and varieties of relationships between all program elements 
such as events, persons and functions, evaluators often create charts or graphical displays 
called logic models to describe programs.6  
 In this case, a program logic model communicating the program’s intended 
components, activities, outputs and outcomes was developed in association with key 
stakeholders at the SCA. The development of the logic model was an important step as the 
“explicit conceptualization of the [program’s] chain of events” 43 assisted the evaluator to 
“draw out the implicit knowledge”6 of SCA personnel. This process allowed the evaluation 
team to come to a common understanding of the program and helped ensure that all areas 
within the scope of the project requiring investigation were addressed. Appendix A 
provides a depiction of FBM’s program theory.  
 As mentioned, the program was described in terms of its components, activities, 
outputs and outcomes. Activities are all the action steps needed to generate program 
outputs and components are major groupings of activities.44 Outputs include the products 
and services provided.44 They are the evidence that the activities occurred. Outcomes are 
“the changes or benefits resulting from activities and outputs.”44  
 The program was broken down into three main components, namely enrolment of 
patients, FBM letter mail-out and processing of completed FBM letters with the activities, 
outputs and outcomes listed beneath. Some of the assumptions implicit in the program’s 
chain of events are provided in dark grey polygons. Each research question, apart from 
physicians’ overall assessment of the usefulness of the program, was associated with one 
or more aspects of the second component of the program. 
 3.6.2 Key Informant Interviews 
 Key informant interviews were conducted to inform the development of the survey 
instrument (Appendices B and C). Key informants were two SCA oncologists, three 
general practitioners and one specialist surgeon. These interviewees were individuals 
whose professional positions gave them unique perspectives on the program and their 
interactions with it.6  
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 Variety in key informants’ backgrounds based on geographic location and specialty 
was desirable because the informants’ contributions were expected to reflect different 
experiences and perspectives. Of the three general practitioners, one worked in an urban 
setting, one in a rural setting and one in a Northern Saskatchewan city. The oncologists and 
community-based surgeon all practiced in metropolitan areas.  
 Semi-structured interview guides with open-ended questions were used to allow for 
focused, conversational, two-way communication.45 The guides included questions that 
were being considered for the survey and others which helped the evaluator understand 
more about physicians’ interactions with FBM. Interviews took place in or near 
physicians’ offices or by phone and lasted between 35 and 60 minutes. 
 Interviews revealed areas of follow-up care that were important to physicians and 
assisted the evaluation committee in understanding potential responses to survey questions. 
Feedback on the wording of questions, response options and domains of questioning was 
considered during the modification of the survey. As a result of the interviews, a number of 
survey questions were added, excluded and modified.  
 3.6.3 Survey Pre-testing 
 Pre-testing of the survey package to be mailed to physicians was conducted before 
large-scale survey distribution. This process was intended to address problems or concerns 
that could arise for respondents from the time of first contact with the survey package to 
the mailing of the questionnaire back to the Cancer Agency.  
 Pre-testing occurred in two stages. To start, a draft of the questionnaire was 
reviewed by members of the SCA’s evaluation committee and my thesis supervisor. This 
process was designed to obtain feedback based on an in-depth knowledge of FBM, 
physician relations and past evaluation experience.46 The first stage answered questions 
such as ‘Have all of the necessary questions been included?’, ‘Can any questions be 
removed?’ and ‘Does the wording of any questions need to be changed?’46  
 Semi-structured pre-test interviews of four physicians (three general or family 
practitioners and one specialist) who had a history of providing follow-up cancer care 
comprised the second stage of pre-testing (Appendix D). This stage was meant to answer 
questions like ‘Are all the words understood?’, ‘Are respondents likely to read and answer 
each question?’, ‘Is useful information obtained from open-ended questions?’ and ‘Does 
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the mailing package create a positive impression?’46 Interviews with physicians, taking 
approximately 30 minutes, were conducted in or near physicians’ offices. Physicians 
completed the questionnaire in 11 to 15 minutes. 
 During these interviews, physicians were handed a survey package and were asked 
to complete the questionnaire as they would if it had been mailed to them.46 The survey 
package included a cover letter, questionnaire, sample FBM letter and a return envelope. 
Physicians were requested not to ask me any questions during this time. I observed 
physicians as they filled out the questionnaire and noted any skipped questions, facial 
expressions and hesitations. After interviewees finished the survey, they were asked about 
any perceived problems. Feedback was also solicited regarding the appropriate use of 
terms, length of time to complete and organization of the questionnaire.  
 A number of changes were made to the survey package based on the feedback 
received during pre-testing. Initially, an envelope with a clear window was used to avoid 
the use of address labels; however, during the first pre-testing interview, the physician 
fumbled with the contents of the survey package, first seeing the back of the FBM letter. 
This led to a change in both the type of outgoing envelope used and the folding of the 
envelope’s contents.  
 A number of comments were received about the excessive lengths of the cover 
letter and questionnaire. In addition, open-ended questions were perceived to place a 
significant burden on respondents. As a result, both the cover letter and questionnaire were 
shortened. Other changes included the rewording of questions to make them clearer, 
putting part of a question in capital letters for emphasis, adding an example of practice 
guidelines to the back of the sample FBM letter and adding response options to a number 
of open- and closed-ended questions. 
 3.6.4 Preparing for Use 
 Patton suggests that “reviewing objectives and establishing precise standards of 
desirability just before data collection increases the likelihood that judgment criteria will 
be up to date, realistic and meaningful.”7 This process has also been found useful in 
alerting evaluation teams to the data they need in order to make sense of and act on results. 
Before data collection, the evaluation committee was asked to consider the levels of survey 
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responses at which the program would be considered ‘highly effective’ and ‘merely 
adequate,’ allowing the team to distinguish excellence from adequacy. 
 3.6.5 Validity and Reliability 
 A measure’s validity is evidenced in how well it captures the concept it is intended 
to measure.7 Reliability, on the other hand, has to do with the consistency of the measure.7 
With a reliable measure, the same results can be achieved time after time as long as the 
situation stays the same.7  
 The validity and reliability of the questionnaire used in this study were not 
established. Using an instrument which has not been subjected to an analysis of its 
psychometric properties can be problematic; however, the concepts addressed by the 
survey were considered straightforward. Consultation with program and evaluation 
experts, a review of the literature, the interviewing of key informants and pre-testing the 
survey were steps used to minimize concerns about the validity and reliability of the 
survey tool.  
 3.6.6 Steps to Achieve a Satisfactory Response Rate 
 The tailored design method of Don Dillman was followed closely during this study 
in an effort to maximize the survey’s response rate.46 His method involves careful attention 
to every aspect of survey development and implementation so that most people are 
motivated to participate and inaccurate or inadequate answers are minimized. Dillman uses 
social exchange theory as a foundation for ensuring design decisions create an effective 
overall survey strategy. This theory takes knowledge about human behaviour and uses it to 
understand why certain people respond to surveys and others do not. Quality self-
administered survey designs are based on two key assumptions: 1) response to a self-
administered questionnaire involves both cognition and motivation and 2) multiple 
contacts with potential respondents are crucial to attaining satisfactory response rates. 
 The first assumption acknowledges that people must understand clearly what is 
being requested and even more, must be motivated to go through the process of answering 
each question and returning the questionnaire to the surveyor.46 The second assumption 
represents the most persistent finding from research on improving response rates. Repeated 
correspondence means that there are a number of chances for help people understand what 
is being asked of them as well as to influence them to complete the actions requested. As a 
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result, each contact is meant to act as a new and unique stimulus to serve its role in the 
survey’s overall system of implementation. 
 According to social exchange theory, three factors are very important for predicting 
a given action: rewards, costs and trust.46 Rewards are what a person expects to get from 
an activity, costs are what one has to relinquish in order to obtain the rewards and trust is 
the expectation that over time the rewards of participation in an activity will be more 
substantial than the costs. As a result, the surveyor must try to enhance the perceived 
rewards and minimize the costs while at the same time gaining the potential respondents’ 
trust so the rewards of responding will outweigh the costs.  
 There are many ways one can attempt to affect the reward, cost, and trust matrix. 
Research shows that prepaid financial incentives, personalization (e.g., name on a cover 
letter) and special contacts such as the use of certified mail, multiple contacts and short 
questionnaires tend to increase response rates.46-48 Other items that seem to positively 
influence responses are stamps on return envelopes and prenotification of the survey by 
phone call from the principal investigator or a physician.47, 48 Efforts that do not appear to 
enhance response rates among physicians are: non-monetary incentives and prenotification 
by mail.47, 48 
 Numerous steps were taken to achieve a satisfactory response rate in this study. 
Before the questionnaire was created, key informant interviews with physicians and 
consultations with experts on FBM helped me better understand physicians’ experiences 
with the program and the issues that were important to physicians and the SCA. 
Discussions with an expert in evaluation were also key in designing the study for optimal 
utility and acceptability to respondents. After much consideration of the information 
collected at this stage and a review of the literature, I developed a list of possible survey 
questions. Once the list of questions was narrowed down through discussions with the 
evaluation committee, the phrasing of each item was more closely examined. Questions 
were formulated to be concise, technically accurate, applicable to physicians’ practices and 
nonjudgmental. In addition, questions were written so that it would be reasonable to expect 
that respondents could recall the answers and that each respondent could indicate the 
answer they wanted to give.  
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 The questionnaire was designed to have a certain visual appeal, show positive 
regard for participants and provide clear mechanisms for navigating the questionnaire. 
Some of the methods used to make the questionnaire visually pleasing were to print the 
survey on a heavy weight, light grey paper, to use italics, underlining and capitalization of 
words sparingly and in a consistent way, to place response options closer to their related 
questions than to other questions and to have a simple cover page. The inconvenience of 
participating was also minimized by making the questionnaire appear as short and easy as 
possible. This appearance was achieved by using open-ended questions sparingly, printing 
the questionnaire as a double-sided booklet and requesting a limited amount of personal 
information from respondents. Positive regard for participants was shown by asking for 
their advice, thanking them for their participation, having an “other” category as a response 
option and including open-ended questions so they were not always constrained by 
selected response options. To help respondents make their way through the survey, I made 
good use of white space, avoiding clutter. For questions with two or more parts, arrows 
clearly indicated whether or not subsequent parts of the question needed to be answered. 
Question and page numbering was also consistent throughout and was not dependent on 
the sections of the questionnaire. 
 Other aspects of the questionnaire used to intentionally enhance response rates 
were: the order of survey questions, the survey implementation process, the construction 
and contents of survey packages and addressing potential privacy concerns. For example, 
the most interesting questions were placed at the beginning of the questionnaire and 
potentially sensitive questions were reserved for later on in the questionnaire.  
 With respect to the survey implementation process, the timing of each survey 
component was purposeful. A number of unique and complementary contacts were made 
with physicians. For example, a prenotification article appeared in the monthly newsletter 
of the provincial medical association about one week before the first questionnaire was 
sent out. This was done to raise awareness of the survey among physicians so they knew 
what the questionnaire was about when it arrived. Another part of the implementation 
process which likely impacted response rates was the effort made to locate physicians 
whose addresses had changed as a result of moves within the province. 
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 The survey packages were constructed with response rates in mind. Since 
physicians normally received FBM letters from the Cancer Agency, the same outgoing 
envelopes were used for the survey packages. It was thought that familiarity with the 
envelope might influence whether or not it got opened. The folding of the package’s 
contents was done carefully so that all items came out together and so the cover letter was 
the first item viewed. A sample copy of the FBM letter was provided to create a common 
reference point for answering the survey questions. Stamps were placed on return 
envelopes since stamps have been shown to improve response rates when compared to 
using business reply envelopes.46 In addition, the cover letter sent with the second mailing 
of the questionnaire was more strongly worded than the first cover letter, providing a new 
stimulus for recipients. It was intended to give the impression that the time to respond was 
running out. 
 Privacy concerns were of the utmost importance in this study and are discussed in 
section 3.11. Briefly, the first cover letter aimed to alleviate potential privacy concerns by 
explaining the use of four-digit identifiers on return envelopes, state the purpose of the 
study, emphasize the study’s potential impact on patient care, provide contact information 
for the SCA and the researchers involved and offer a summary report of results. In 
addition, cover letters were signed by the executive director of the cancer centres and the 
SCA’s logo and return address were used to increase the perceived legitimacy of the 
project.  
3.7 Questionnaire Distribution and Data Collection 
 Mailings and notifications regarding the survey were made to potential respondents 
on the following dates in 2005: 
 
• Prenotification  First week of June 
• First survey   June 13 
• Reminder letter June 20 
• Second survey July 4 
 
 The first mail-out of the questionnaire was preceded by prenotification of the 
survey via an article in the Saskatchewan Medical Association’s monthly newsletter, SMA 
News. Survey packages were subsequently sent out to 987 physicians within a week of the 
prenotification article’s publication. The survey package included a detailed cover letter, 
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the questionnaire, a sample FBM letter and a self-addressed stamped return envelope. A 
thank you/reminder letter was then sent to all physicians one week after the first survey 
package went out. This letter expressed appreciation for returned surveys and the hopes 
that unreturned questionnaires would soon be completed and returned. For the mailing of 
the second survey package, a modified cover letter along with a replacement questionnaire 
was sent three weeks after the first survey to physicians who had not yet responded.  
 Surveys were printed as double-sided booklets and were sent in three different 
fonts which were used to differentiate physicians based on the relative number of follow-
up patients they had (i.e., low, intermediate or high). To determine the number of patients 
defining the low, intermediate and high categories, physicians’ names were sorted based on 
the absolute number of their FBM patients. Physicians were then divided as evenly as 
possible into three groups. The first third of physicians had one to seven FBM patients (i.e. 
low category), the second group had eight to twenty-two patients (i.e. intermediate 
category) and the final group had twenty-three or more FBM patients (i.e. high category). 
All envelopes for outgoing mailings included the SCA’s return address, the participant’s 
address and metered postage. Cover letters were signed by the executive director of the 
Saskatoon Cancer Centre and were on SCA letterhead. Completed surveys were returned 
in self-addressed stamped envelopes to the evaluator care of the Saskatoon Cancer Centre. 
Efforts were made to get accurate mailing information for undeliverable survey packages. 
3.8 Data Entry 
 Data from completed questionnaires was entered into Epi Info™ and later 
transferred into SPSS™ 10.0. The data entry template and the entering of data were 
completed by health records personnel at the SCA and myself. Restrictions were placed on 
the types of values that could be entered to enhance the accuracy of the data. Special codes 
were assigned for missing data and atypical responses. A spreadsheet of issues arising 
during data entry was kept, which I later addressed on an individual basis. 
3.9 Data Cleaning and Checking 
 Upon completion of data entry, the data were checked visually for obvious errors. 
Summary reports for each variable were produced listing the frequencies of responses, 
minimum and maximum values, atypical answers and missing data. Data for certain 
variables were assessed for consistency with previously answered questions. To identify 
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any further errors, a 10% random sample of data was drawn and checked for accuracy 
against hard copies of respondents’ questionnaires. Data were subsequently rechecked and 
any errors were corrected. 
3.10 Data Analysis 
 Statistical analyses were performed using SPSS™ 11.0.  
 A subset of the data collected is described in Chapter 4 to address the research 
questions listed in section 1.6. Descriptive analyses are provided for survey questions 
related to physicians’ overall impression of FBM (survey questions 2, 4, 5, and 23), 
physicians’ information and training needs (survey questions 10-12) and physicians’ 
confidence in their skills for providing follow-up care (survey question 9). A 
comprehensive and descriptive report was submitted to the SCA including the findings for 
all survey questions. 
 Demographic variables and other variables of importance, as determined through a 
review of the literature and consultation with experts, were analyzed using chi-square and 
t-tests (bivariate analysis), depending on the type of variable, to determine independent 
factors associated with physicians’ needs for additional patient information, clinical 
information and training and physician confidence for following various cancers. All 
variables associated with the outcome variables (p < 0.25) in the bivariate analysis were 
entered into a multiple logistic regression model (multivariate analysis). Variables that had 
significant associations (p < 0.10) with the dependent variable in the preliminary 
regression analysis were then re-entered into the analysis and a final model of independent 
correlates was obtained. The type I error rate or significance level for the final logistic 
regression analysis was set at α = 0.05. 
 In logistic regression analysis, the interest is in estimating the probability of 
predicting the value of the dependent variable as a function of a number of independent 
correlates or predictors. Logistic regression allows researchers to identify variables 
correlated to the dependent variable which help predict the outcome of interest when the 
dependent variable is dichotomous.49 Independent variables may be continuous or 
categorical. This method of analysis can also be used to determine the relative importance 
of the independent variables and assess interaction effects. 
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 Using maximum likelihood estimation, logistic regression adjusts for the estimated 
effects of each independent variable for differences in the distributions of other 
independent variables and associations among other independent variables. Adjusted odds 
ratios, which adjust for all other independent variables in the regression model, are used to 
express the strength of the association between independent variables and the dependent 
variable. 
 This method of analysis was used for the outcome variables regarding physicians’ 
information and training needs since they were dichotomous, that is, possible responses to 
the relevant survey questions were ‘yes’ and ‘no’. For outcome variables on physician 
confidence, the desired response was ‘very confident’. All other responses, excluding ‘not 
applicable’, were considered less favorable and were grouped into the category ‘less than 
very confident’, making these outcome variables dichotomous. In addition, for each 
outcome variable, numerous independent variables were being considered for their relative 
roles in predicting the outcomes of interest. 
 A number of variables were re-classified for the bivariate and multivariate analyses 
(Table 3.1). For questions relating to physicians’ needs for additional patient information, 
clinical information and training, a composite measure of physician confidence was 
constructed to be used as an independent variable in the regression analysis. To calculate 
this composite measure, responses to individual questions on physician confidence were 
assigned values as follows: “very confident” = 1, “somewhat confident” = 2, “somewhat 
unconfident” = 3 and “very unconfident” = 4. Scores for each of the questions on 
confidence were summed, then divided by the number of confidence questions answered. 
This produced an average measure of physician confidence and is referred to in the 
regression models as “physician confidence.” Responses of “not applicable” were not 
included in this calculation.  
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Table 3.1: Re-classified variables for bivariate and multivariate analyses 
 
Category 
 
Original Variable New Variable 
Number of physicians in 
primary medical office 
Continuous (number of 
physicians) 
1. Solo practice 
2. Small group practice
3. Medium group 
practice 
4. Large group practice
Physician confidence (for 
individual cancers) 
1. Very confident 
2. Somewhat confident 
3. Somewhat unconfident 
4. Very unconfident 
1. Very confident 
2. Less than very 
confident 
Physician confidence (overall 
average) 
Separate responses for each 
of 6 questions on physician 
confidence by cancer type 
Average score calculated 
from responses to each 
of 6 questions on 
physician confidence 
Program usefulness 1. Very useful 
2. Somewhat useful 
1. Very or somewhat 
useful 
3. Neutral 2. Neutral 
4. Not very useful 
5. Not useful at all 
 
 
3. Not very useful or 
not useful at all 
 Written comments for the open-ended components of questions 10 to 12 underwent 
content analysis. This method is widely used for analyzing such data.50 I read the responses 
repeatedly without seeking predetermined categories or themes in order to immerse myself 
in the data.51 Recurring themes were subsequently drawn out of the data. 
3.11 Ethical Considerations 
 Ethical approval for this study was obtained from the University of Saskatchewan 
Behavioural Research Ethics Board (Appendix K). Members of the survey population were 
informed about the project’s purpose, the nature of participation, the time commitment 
involved, the intended use of the information collected and the anticipated benefits of the 
project. Consent to participate was implied with the return of the questionnaire.  
 Privacy concerns were of the utmost importance during this project. Concerns 
around confidentiality and anonymity were considered key in influencing survey response 
rates, the quality of survey data and physicians’ perceptions of both the evaluation and the 
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Cancer Agency. As a result, the evaluation’s methodology was closely tailored to the needs 
of the primary intended users, study participants and the evaluator.  
 A number of steps were taken to alleviate potential privacy concerns of 
respondents. For example, the cover letter included in the first survey package explained 
the use of the unique four-digit identifier on return envelopes as being for mailing purposes 
only. These identifiers allowed me to remove respondents from a subsequent mailing list. 
This ensured that only those who did not respond to the first copy of the survey would be 
sent a second copy and that the SCA itself would not be able to link individual survey 
responses to a particular physician. Physicians were informed that the file linking 
participants’ names and addresses to identifiers would be destroyed after the last mailing 
was complete and that data would only be presented in aggregate form. As a result, survey 
responses were confidential, but not anonymous. Respondents were invited to contact the 
Office of Research Services, the SCA or the researchers involved with any questions they 
had. To acknowledge respondents’ contributions, a summary of the study’s results was 
offered upon request. The authority of the SCA, the involvement of an external evaluator 
and limiting requests for personal information were some of the other ways in which 
potential privacy concerns were handled. 
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CHAPTER 4 
 
RESULTS 
 
 
 This chapter begins by stating the survey’s response rate and participant 
characteristics, followed by a report of the study’s findings as they relate to the research 
questions found in Section 1.6.  
 
4.1 Response Rate 
 The survey was sent to 987 general and family practitioners and specialists who 
provide follow-up cancer care. A general practitioner (GP) is a physician with a general 
license to practice medicine in Saskatchewan while family practitioners have a Certificate 
from the College of Family Physicians of Canada in addition to this license. For ease of 
reporting, those physicians indicating they were GPs or in family practice are herein 
referred to as GPs, since physicians in family practice more appropriately fit into the 
category of GPs than GPs being included in a family practice category. It was found that 
36 physicians had moved out of province or could not be located, 8 were no longer 
licensed, 6 had retired, 5 were on leave and 7 were not eligible to participate for other 
reasons. Of the 925 eligible physicians, 486 or 52.5% responded to the survey. One survey 
was not included in the analysis as it was received several months after the cut-off date. 
4.2 Participant Characteristics 
 Table 4.1 shows various characteristics of the responding physicians and compares 
them with the total population of physicians providing community-based follow-up care 
when possible.  
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Table 4.1: Demographics Profile 
 
Characteristic % of 
Respondents 
(n) 
% of All FBM 
Physicians 
(n) 
Sex 
     Male 70.5% (342) - 
     Female 26.6% (129) - 
     Did not specify 2.9% (14) - 
Specialty*
     General practice 73.4% (356) 77.0% (712) 
     Specialists 23.7% (115) 23.0% (213) 
     Did not specify 2.9% (14) - 
Number of follow-up patients**
     Low (1-7 patients) 25.8% (125) 33.5% (310) 
     Intermediate (8-22 patients)  34.8% (169) 32.1% (297) 
     High (23+ patients) 39.4% (191) 34.4% (318) 
Years in clinical practice  
     0 - 5 yrs 8.0%  (39) - 
     6 - 10 yrs 11.1% (54) - 
     11 - 15 yrs 14.8% (72) - 
     16 yrs+ 63.3% (307) - 
     Did not specify 2.7% (13)  
Years in clinical practice in Saskatchewan 
     0 - 5 yrs 26.6% (129) - 
     6 - 10 yrs 13.4% (65) - 
     11 - 15 yrs 10.5% (51) - 
     16 yrs+ 46.8% (227) - 
     Did not specify 2.7% (13) - 
Number of physicians in primary medical office 
     Solo practice (1 physician) 21.9% (106) - 
     Small group practice (2-4 physicians) 26.8% (130) - 
     Medium group practice (5-7 physicians) 24.5% (119) - 
     Large group practice (8+ physicians) 20.6% (100) - 
     Did not specify 6.2% (30) - 
Location of practice 
     Metropolitan (Regina or Saskatoon) 51.3% (249) - 
     Urban (city of 10,000+, except Regina and Saskatoon) 19.2% (93) - 
     Rural (city/town/village/hamlet of fewer than 10,000) 25.9% (126) - 
     Did not specify 3.5% (17) - 
* For comparison of respondents and non-respondents, X2 = 1.045, p=0.307 
** For comparison of respondents and non-respondents, X2 = 28.03, p<0.001 
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 Over 70% (70.5%) of respondents were male. Almost three-quarters (73.4%) of 
respondents were GPs and over three-quarters (77.0%) of physicians in the total 
population of physicians providing follow-up care were GPs. Chi-square analyses 
showed no significant differences between respondents and non-respondents based on 
physician specialty (p=0.307).  
 Physicians with high numbers of follow-up patients represented 39.4% of 
respondents while 34.8% of respondents had an intermediate number of follow-up 
patients. One-quarter (25.8%) of responding physicians had low numbers of follow-up 
patients. Chi-square analyses revealed significant differences between respondents and 
non-respondents based on relative number of FBM patients (p<0.001). Over three fifths 
(63.3%) of respondents had been practicing for 16 years or more and 46.8% had been 
practicing in Saskatchewan for 16 or more years. Similar percentages of physicians were 
in solo practices and all sizes of group practices. 
 About half of respondents (51.3%) practiced in metropolitan centres while 25.9% 
worked in rural Saskatchewan and 19.2% worked in urban areas other than Saskatoon or 
Regina. Of the responding physicians in general practice, 47.3% worked in the 
metropolitan centres of Regina or Saskatoon, while 17.9% worked in urban, non-
metropolitan areas and 34.8% worked in rural communities. Most responding specialists 
worked in metropolitan areas (71.9%).  
4.3 Survey Findings 
 4.3.1 Overall perceptions of FBM 
  4.3.1.1 Program Usefulness  
 The majority (72.3%) of responding physicians felt the follow-up program was 
very useful to them as they provided follow-up care, while 19.2% thought it was 
somewhat useful (Figure 4.1). A small proportion of respondents thought the program 
was not very useful or not useful at all (1.3% and 1.1%, respectively).  
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Figure 4.1: Usefulness of FBM Program (n=473) 
 
  4.3.1.2 Usefulness of FBM Letter as a Reminder 
 The follow-up letter was found to be a very important reminder for 72.0% of 
physicians to see their cancer patients for follow-up and a somewhat important reminder 
for 18.2%. The letter was somewhat unimportant for 1.7% of physicians and very 
unimportant for 2.3% of physicians. A small percentage (5.8%) of physicians was neutral 
about whether or not the letter was an important reminder. 
  4.3.1.3 Information on the Timing of Follow-up Tests and Procedures 
 Of all respondents, 26.7% said FBM letters were always clear about the timing of 
tests and procedures to be done during the follow-up phase of care and 48.2% said FBM 
letters were usually clear in this regard. Fifteen percent said the timing of tests and 
procedures was sometimes clear, 6.7% said the timing was rarely clear and 3.3% said it 
was never clear. 
  4.3.1.4 Content of Follow-up Letters 
 Excluding those who were not sure about their level of satisfaction, 44.9% of 
respondents said they were very satisfied with the content of follow-up letters. Two fifths 
(40.4%) of respondents were somewhat satisfied while 2.4% and 0.6% were somewhat 
and very dissatisfied, respectively. Just over one tenth (11.8%) of respondents were 
neither satisfied nor dissatisfied with the content of the letters.  
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 4.3.2 Physicians’ Information Needs 
  4.3.2.1 Need for Additional Patient Information 
 Three fifths of physicians (59.3%) said they needed additional patient information 
to do follow-up. Respondents saying they needed more patient information were asked to 
indicate the types of information that would be helpful for them as they provided follow-
up care. Physicians most wanted the patient’s prognosis (87.9%), followed by the last 
known cancer status (55.0%), cancer type (43.2%) and “other” patient information 
(19.6%). 
 The most frequent response specified under the “other” category accounted for 
40% of such responses and related to the need for a clear follow-up plan including items 
such as the required follow-up bloodwork and tests and their timing or frequency. Other 
responses related to the desire for copies of laboratory and investigative reports, clinical 
practice guidelines and patient histories from the time patients attended a cancer clinic, 
including treatments received, referrals and test results.  
 Table 4.2 shows the bivariate associations between physician-related variables 
and the outcome variable, the need for additional patient information. Variables with p-
values of less than or equal to 0.25 for at least one response option were retained for 
inclusion in subsequent multivariate regression models. All variables tested qualified for 
further analyses except years in clinical practice. 
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Table 4.2: Bivariate associations between physician-related variables and the need 
for additional patient information 
 
Variable, n (%) 
 
OR 95% CI p-value 
Sex    
     Male REF   
     Female 2.046 1.314, 3.186 0.002 
Number of follow-up patients    
     Low REF   
     Intermediate 0.875 0.536, 1.427 0.592 
     High 0.598 0.373, 0.959 0.033 
Specialty    
     General practice REF   
     Specialists 0.370 0.240, 0.570 <0.001 
Years in clinical practice    
     0 - 5 yrs REF   
     6 - 10 yrs 1.101 0.455, 2.666 0.831 
     11 - 15 yrs 0.799 0.351, 1.817 0.592 
     16 yrs+ 0.666 0.328, 1.351 0.260 
Years in clinical practice in Saskatchewan    
     0 - 5 yrs REF   
     6 - 10 yrs 0.529 0.283, 0.987 0.046 
     11 - 15 yrs 0.542 0.276, 1.063 0.075 
     16 yrs+ 0.471 0.296, 0.750 0.002 
Number of physicians in primary medical 
office 
   
     Solo practice 0.547 0.311, 0.036 0.036 
     Small group practice 1.377 0.790, 2.401 0.259 
     Medium group practice 0.960 0.553, 1.669 0.885 
     Large group practice REF   
Location of practice    
     Metropolitan REF   
     Urban 2.023 1.213, 3.376 0.007 
     Rural 1.625 1.043, 2.531 0.032 
Program usefulness    
     Very or somewhat useful 2.304 0.640, 8.285 0.201 
     Neutral 1.125 0.259, 4.893 0.875 
     Not very useful or not useful at all REF   
Physician confidence* n/a n/a <0.001 
*A t-test was performed for this variable. All other variables underwent chi-square tests. 
 
 Continuing from an investigation of bivariate associations and preparing for 
regression analysis, the next step in analyzing the data was to check for interactions 
between potential correlates. Using the log-likelihood ratio test (LRT), an interaction 
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effect was seen between the variables ‘number of physicians in primary medical office’ 
and ‘location of practice.’ As a result, a first-order interaction term was included in the 
subsequent regression analysis. 
 The final step was to perform the regression analysis. Variables selected through 
the bivariate analysis plus the interaction term were entered into the regression model. 
Those variables that had a significant association (p < 0.10) with the need for additional 
patient information were then re-entered into the regression analysis and a final model 
was obtained. Correlates in the final model were required to have p-values of less than 
0.05. 
 Table 4.3 depicts the final regression model. The model included: physician sex, 
physician specialty, number physicians in primary medical office, location of practice, 
physician confidence and the interaction term between the number of physicians in the 
primary medical office and location of practice. 
 
Table 4.3: Final multivariate model showing the relationship between physician-
related variables and the need for additional patient information 
 
Variable ORadj 95% CI p-value 
Sex    
     Male REF   
     Female 2.043 1.237, 3.373 0.005 
Specialty    
     General practice REF   
     Specialists 0.490 0.276, 0.871 0.015 
Number of physicians in primary medical 
office 
   
     Solo practice REF   
     Small group practice 1.314 0.571, 3.023 0.520 
     Medium group practice 0.509 0.157, 1.652 0.261 
     Large group practice 0.318 0.073, 1.3383 0.127 
Location of practice    
     Metropolitan REF   
     Urban 1.041 0.422, 2.565 0.931 
     Rural 0.398 0.110, 1.446 0.161 
Interaction term 
      Number of physicians in primary medical 
      office x Location of practice 
1.351 1.039, 1.756 0.025 
Physician confidence 1.668 1.136, 2.448 0.009 
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 The associations between the need for additional patient information and the 
variables ‘number of physicians in primary medical office’ and ‘location of practice’ 
were not interpreted independently since an interaction effect was observed between the 
latter two variables. As a result, the nature of the relationship between the dependent 
variable and physicians’ location of practice was contingent on the number of clinicians 
in the physicians’ primary medical office. Similarly, the nature of the relationship 
between the dependent variable and the number of physicians in the primary medical 
office depended on physicians’ location of practice (Figure 4.2). The most linear 
relationship between the need for additional patient information and the number of 
physicians in the primary practice was seen for rural physicians. As the number of 
physicians in a rural practice increased, the need for additional information tended to 
increase. The highest percentages of metropolitan and urban physicians needing more 
information were in small group practices. Of all groups, the lowest reported need for 
additional patient information was among solo practice physicians in rural and 
metropolitan areas. 
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Figure 4.2: Need for Additional Patient Information by Practice  
Size and Location of Practice 
 
 
  4.3.2.2 Need for Additional Clinical Information 
 Almost three quarters (73.0%) of physicians said additional clinical information 
related to follow-up would help them improve their practice of follow-up. Physicians 
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who felt additional clinical information would assist them were asked which subject areas 
of information would be most important to them. Due to some irregularities in the way 
responses were given, subject areas were analyzed not by rankings as planned but rather 
as yes/no responses. 
 Clinical practice guidelines were chosen by 78.2% of respondents as the most 
needed subject of clinical information, followed by drug information (67.4%), timing of 
bloodwork (57.9%), advances in cancer treatments (52.9%), managing the psychosocial 
needs of patients (26.8%) and ‘other’ (2.1%). 
 Physicians desiring more clinical information were also asked which information 
sources would be most preferable to them. For this question, respondents were asked to 
rank various possible information sources with ‘1’ indicating the most useful source, ‘2’ 
indicating the second most useful source and so on. A number of physicians, however, 
responded using checkmarks. Due to these irregularities in the way responses were 
provided, only ranked responses were used in the analysis unless only one checkmark 
was made, in which case the checkmark was accepted as a ‘number one’ ranking.  
 The ‘number one’ ranked information sources for clinical information were 
printed materials (41.5%), continuing medical education (39.2%), a resource person 
(10.3%), online resources (8.4%) and “other” (0.6%). The ‘number two’ ranked 
information sources were printed materials (30.1%), continuing medical education 
(29.3%), online resources (23.2%) and a resource person (17.4%).  
 Table 4.2 shows the bivariate associations between physician-related variables 
and the outcome variable, the need for additional clinical information. All variables, 
except number of follow-up patients, exhibited p-values of less than or equal to 0.25 and, 
as a result, were retained for further analyses. 
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Table 4.4: Bivariate associations between physician-related variables and the need 
for additional clinical information 
 
Variable, n (%) 
 
OR 95% CI p-value 
Sex    
     Male REF   
     Female 4.750 2.513, 8.978 <0.001 
Number of follow-up patients    
     Low REF   
     Intermediate 1.028 0.597, 1.770 0.922 
     High 0.783 0.466, 1.315 0.354 
Specialty    
     General practice REF   
     Specialists 0.242 0.153, 0.381 <0.001 
Years in clinical practice    
     0 - 5 yrs REF   
     6 - 10 yrs 1.069 0.360, 3.173 0.904 
     11 - 15 yrs 0.569 0.216, 1.496 0.253 
     16 yrs+ 0.516 0.220, 1.213 0.129 
Years in clinical practice in 
Saskatchewan 
   
     0 - 5 yrs REF   
     6 - 10 yrs 0.709 0.340, 1.476 0.358 
     11 - 15 yrs 0.475 0.226, 0.999 0.050 
     16 yrs+ 0.452 0.266, 0.770 0.003 
Number of physicians in primary 
medical office 
   
     Solo practice 0.420 0.223, 0.791 0.007 
     Small group practice 1.136 0.586, 2.204 0.705 
     Medium group practice 0.698 0.369, 1.321 0.269 
     Large group practice REF   
Location of practice    
     Metropolitan REF   
     Urban 1.923 1.087, 3.404 0.025 
     Rural 1.861 1.119, 3.095 0.017 
Program usefulness    
     Very or somewhat useful 4.431 1.227, 15.996 0.023 
     Neutral 2.182 0.497, 9.583 0.301 
     Not very useful or not useful at all REF   
Physician confidence* n/a n/a <0.001 
*A t-test was performed for this variable. All other variables underwent chi-square tests. 
 
 Following the bivariate analysis, variables were assessed for interaction effects. 
Using the previously described method (see section 4.3.2.1), interactions were seen 
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between the following pairs of variables: number of physicians in primary medical office 
and location of practice; number of physicians in primary medical office and physician 
specialty; and physician sex and specialty. As a result, three first-order interaction terms 
were submitted to the regression analysis. 
 Table 4.5 depicts the final logistic regression model. The model included: 
physician sex, physician specialty, number physicians in primary medical office, location 
of practice, physician confidence and two first-order interaction terms. One interaction 
term was between the number physicians in primary medical office and location of 
practice. The other interaction term was between physician sex and specialty. 
 
Table 4.5: Final multivariate model showing the relationship between physician-
related variables and the need for additional clinical information 
 
Variable 
 
ORadj 95% CI p-value 
Sex    
     Male REF   
     Female 104.843 8.821, 1246.115* <0.001 
Specialty    
     General practice REF   
     Specialists 5.555 0.781, 39.484* 0.087 
Number of physicians in primary medical 
office 
   
     Solo practice REF   
     Small group practice 1.264 0.461, 3.465 0.649 
     Medium group practice 0.301 0.076, 1.199 0.089 
     Large group practice 0.196 0.035, 1.110 0.065 
Location of practice    
     Metropolitan REF   
     Urban 0.973 0.329, 2.877 0.960 
     Rural 0.288 0.065, 1.270 0.100 
Interaction term 
      Number of physicians in primary 
      medical office x Location of practice 
1.533 1.104, 2.130 0.011 
Interaction term 
      Sex x Specialty 
0.107 0.021, 0.545 0.007 
Physician confidence 1.569 0.995, 2.476 0.053 
* A three-way crosstabulation between the need for additional clinical information, sex and specialty 
revealed small cell sizes (<12) for three cells. This case is likely to be the cause of large confidence 
intervals for the independent variables sex and specialty. 
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 As expected, the final regression analysis revealed that lower physician 
confidence was associated with a need for more clinical information. This finding was 
consistent with the association found between physician confidence and the need for 
additional patient information. 
 The associations between the need for additional clinical information and the 
variables ‘number of physicians in primary medical office’ and ‘location of practice’ 
were not interpreted independently since an interaction effect was observed between the 
latter two variables. The nature of the relationships between the dependent variable and 
these two variables was similar to that seen for the need for additional patient information 
(Figure 4.3). The lowest need for additional clinical information was again seen for solo 
practice physicians working in rural and metropolitan areas.  
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Figure 4.3: Need for Additional Clinical Information by Practice  
Size and Location of Practice 
 
 
 Associations between the need for additional clinical information and the 
variables ‘sex’ and ‘specialty’ were also not interpreted independently due to an 
interaction effect between sex and specialty. Female gender appeared to have a stronger 
influence on the relationship between the dependent variable and specialty than male 
gender, that is, the difference between the need for more clinical information for female 
GPs as opposed to specialists was greater than for male GPs and specialists (Figure 4.4). 
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Figure 4.4: Need for Additional Clinical Information by Physician Sex and Specialty 
 
  4.3.2.3 Physicians’ Training Needs 
 Over one third (34.9%) of physicians felt they needed more training on follow-up 
care. Physicians who needed training were asked to indicate the type of training they 
needed and the best way to deliver it. Ninety-three comments were analyzed for the 
subject areas physicians would like to see included in training initiatives. Over two fifths 
(43.0%) of physicians wanted to learn more about the plan for follow-up including such 
aspects as clinical practice guidelines, what is expected of the physicians providing 
follow-up care and the timing of bloodwork. About one fifth (21.5%) of physicians 
wanted more training on cancer treatments and 10.8% wanted more training regarding 
pharmaceuticals as they relate to cancer care. Additional training in managing patients’ 
psychosocial needs and palliative care were of interest to 6.5% and 4.3% of physicians, 
respectively. For a complete analysis of respondents’ comments, see Appendix L.  
 A total of 145 comments were analyzed for suggestions on the format of training 
sessions. Almost half (46.8%) of physicians wanted the training to be approved as 
continuing medical education sessions while similar percentages of physicians wanted 
seminars/lectures, online training and printed materials at 15.9%, 13.8% and 12.4%, 
respectively. Less than one tenth (8.3%) of respondents wanted the training to be in the 
form of courses. For a complete analysis of respondents’ comments, see Appendix M. 
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 Table 4.6 shows the bivariate associations between physician-related variables 
and the outcome variable, the need for additional training on follow-up care. All 
variables, except number of follow-up patients and program usefulness, exhibited p-
values of less than or equal to 0.25. These variables were retained for further analyses. In 
addition, program usefulness was retained as the overall p-value for the variable was 
0.145. 
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Table 4.6: Bivariate associations between physician-related variables and the need 
for additional training on follow-up care 
 
Variable, n (%) 
 
OR 95% CI p-value 
Sex    
     Male REF   
     Female 1.871 1.220, 2.868 0.004 
Number of follow-up patients    
     Low REF   
     Intermediate 0.954 0.583, 1.560 0.850 
     High 0.757 0.467, 1.228 0.259 
Specialty    
     General practice REF   
     Specialists 0.141 0.073, 0.273 <0.001 
Years in clinical practice    
     0 - 5 yrs REF   
     6 - 10 yrs 0.656 0.279, 1.542 0.334 
     11 - 15 yrs 0.522 0.230, 1.183 0.119 
     16 yrs+ 0.470 0.234, 0.944 0.034 
Years in clinical practice in 
Saskatchewan 
   
     0 - 5 yrs REF   
     6 - 10 yrs 0.461 0.242, 0.876 0.018 
     11 - 15 yrs 0.471 0.233, 0.950 0.035 
     16 yrs+ 0.436 0.276, 0.690 <0.001 
Number of physicians in primary 
medical office 
   
     Solo practice 0.482 0.263, 0.885 0.019 
     Small group practice 0.861 0.497, 1.491 0.593 
     Medium group practice 0.889 0.507, 1.559 0.682 
     Large group practice REF   
Location of practice    
     Metropolitan REF   
     Urban 1.021 0.604, 1.725 0.939 
     Rural 1.762 1.120, 2.770 0.014 
Program usefulness    
     Very or somewhat useful 2.262 0.474, 10.790 0.306 
     Neutral 0.952 0.153, 5.942 0.958 
     Not very useful or not useful at all REF   
Physician confidence*   <0.001 
*A t-test was performed for this variable. All other variables underwent chi-square tests. 
 
 Table 4.7 depicts the final logistic regression model. The model included 
physician specialty and physician confidence. Interaction effects were seen between years 
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in clinical practice in Saskatchewan and location of practice as well as between years in 
clinical practice and location of practice; however, the interaction terms did not remain 
significant in the final model. 
 
Table 4.7: Final multivariate model showing the relationship between physician-
related variables and the need for more training on follow-up care 
 
Variable 
 
ORadj 95% CI p-value 
Specialty    
     General practice REF   
     Specialists 0.233 0.116, 0.468 <0.001 
Physician confidence 2.734 1.875, 3.985 <0.001 
 
 
 4.3.3 Physician Confidence in Following Cancers 
 This section presents physicians’ levels of confidence in their skills for following 
six cancers, namely, breast, colorectal, lung, prostate and gynecological cancers as well 
as lymphomas. The results of bivariate and logistic regression analyses are also provided. 
For the regression analyses, physicians’ responses regarding confidence were grouped 
into two categories: very confident and less than very confident, with very confident as 
the desired response. Final regression models are reported for each cancer type. No 
interaction effects were observed between potential correlates. 
  4.3.3.1 Breast Cancer 
 Excluding those who said the question was not applicable to them, 54.2% of 
respondents said they were very confident they had the skills to do follow-up for breast 
cancer. Two fifths (40.8%) of physicians were somewhat confident while 4.0% were 
somewhat unconfident and 1.0% were very unconfident (Figure 4.5). 
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Figure 4.5: Physician confidence in following breast cancer (n=404) 
 
 
 Table 4.8 shows the bivariate associations between physician-related variables 
and the outcome variable, physician confidence in following breast cancer. All variables, 
except physician sex, years in clinical practice and location of practice, exhibited p-
values of less than or equal to 0.25 and, as a result, were retained for further analyses. 
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Table 4.8: Bivariate associations between physician-related variables and physician 
confidence in following breast cancer 
 
Variable, n (%) 
 
OR 95% CI p-value 
Sex    
     Male REF   
     Female 0.988 0.642, 1.520 0.955 
Number of follow-up patients    
     Low REF   
     Intermediate 0.640 0.377, 1.086 0.098 
     High 0.388 0.230, 0.655 <0.001 
Specialty    
     General practice REF   
     Specialists 0.315 0.156, 0.637 0.001 
Years in clinical practice    
     0 - 5 yrs REF   
     6 - 10 yrs 1.190 0.490, 2.893 0.700 
     11 - 15 yrs 0.771 0.333, 1.785 0.544 
     16 yrs+ 0.778 0.380, 1.592 0.492 
Years in clinical practice in Saskatchewan    
     0 - 5 yrs REF   
     6 - 10 yrs 0.628 0.328, 1.200 0.159 
     11 - 15 yrs 0.599 0.292, 1.228 0.162 
     16 yrs+ 0.601 0.378, 0.956 0.032 
Number of physicians in primary medical 
office 
   
     Solo practice 0.461 0.251, 0.847 0.013 
     Small group practice 0.757 0.438, 1.308 0.318 
     Medium group practice 0.692 0.394, 1.214 0.199 
     Large group practice REF   
Location of practice    
     Metropolitan REF   
     Urban 1.084 0.646, 1.820 0.759 
     Rural 0.958 0.606, 1.512 0.852 
Need for additional patient information    
     Yes 0.576 0.373, 0.892 0.008 
     No REF   
Need for additional clinical information    
     Yes 0.513 0.314, 0.840 0.008 
     No REF   
Need for more training on follow-up     
     Yes 0.406 0.268, 0.615 <0.001 
     No REF   
Program usefulness    
     Very or somewhat useful 0.412 0.075, 2.278 0.310 
     Neutral 0.450 0.066, 3.074 0.415 
     Not very useful or not useful at all REF   
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 Table 4.9 depicts the final logistic regression model. The model included the 
number of follow-up patients, physician specialty and the need for more training on 
follow-up care. Physicians with greater numbers of FBM patients were more likely to be 
very confident in their skills for following breast cancer. Specialists were three times 
more likely to be confident in following breast cancer than GPs. In addition, physicians 
who needed additional training on follow-up care were 2.2 times more likely to be less 
than very confident.  
 
Table 4.9: Final multivariate model showing the relationship between physician-
related variables and physician confidence for following breast cancer 
 
Variable ORadj 95% CI p-value 
Number of follow-up patients    
     Low REF   
     Intermediate 0.576 0.327, 1.017 0.057 
     High 0.352 0.201, 0.617 <0.001 
Specialty    
     General practice REF   
     Specialists 0.327 0.150, 0.710 0.005 
Need for more training on follow-up care    
     Yes 2.204 1.430, 3.398 <0.001 
     No REF   
 
  4.3.3.2 Colorectal Cancer 
 Excluding those who said the question was not applicable to them, 44.3% of 
respondents said they were very confident they had the skills to do follow-up for 
colorectal cancer. This result was in the middle of the range of values seen for physician 
confidence among the cancers. Almost half (48.0%) of physicians were somewhat 
confident while 5.2% were somewhat unconfident and 2.5% were very unconfident 
(Figure 4.6). 
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Figure 4.6: Physician confidence in following colorectal cancer (n=404) 
 
 
 Table 4.10 shows the bivariate associations between physician-related variables 
and the outcome variable, physician confidence in following colorectal cancer. All 
variables, except years in clinical practice, years in clinical practice in Saskatchewan, 
location of practice and program usefulness, were retained for further analyses. 
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Table 4.10: Bivariate associations between physician-related variables and physician 
confidence in following colorectal cancer 
 
Variable, n (%) 
 
OR 95% CI p-value 
Sex    
     Male REF   
     Female 1.577 1.103, 2.455 0.044 
Number of follow-up patients    
     Low REF   
     Intermediate 0.687 0.395, 1.194 0.183 
     High 0.329 0.192, 0.566 <0.001 
Specialty    
     General practice REF   
     Specialists 0.178 0.086, 0.370 <0.001 
Years in clinical practice    
     0 - 5 yrs REF   
     6 - 10 yrs 1.146 0.462, 2.846 0.769 
     11 - 15 yrs 0.928 0.394, 2.183 0.864 
     16 yrs+ 0.882 0.424, 1.835 0.736 
Years in clinical practice in Saskatchewan    
     0 - 5 yrs REF   
     6 - 10 yrs 0.738 0.386, 1.412 0.359 
     11 - 15 yrs 0.686 0.334, 1.409 0.305 
     16 yrs+ 0.861 0.539, 1.375 0.532 
Number of physicians in primary medical 
office 
   
     Solo practice 0.446 0.241, 0.826 0.010 
     Small group practice 0.561 0.317, 0.993 0.047 
     Medium group practice 0.571 0.319, 1.023 0.060 
     Large group practice REF   
Location of practice    
     Metropolitan REF   
     Urban 1.118 0.659, 1.898 0.679 
     Rural 0.852 0.540, 1.342 0.489 
Need for additional patient information    
     Yes 0.535 0.354, 0.810 0.003 
     No REF   
Need for additional clinical information    
     Yes 0.439 0.273, 0.706 0.001 
     No REF   
Need for more training on follow-up care    
     Yes 0.373 0.243, 0.573 <0.001 
     No REF   
Program usefulness    
     Very or somewhat useful 0.633 0.115, 3.501 0.601 
     Neutral 0.500 0.072, 3.454 0.482 
     Not very useful or not useful at all REF   
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 The final logistic regression model for physician confidence in following 
colorectal cancer included number of follow-up patients, physician specialty and the need 
for more training of follow-up care (Table 4.11). This model was the same as that for 
breast cancer, only this time specialists were over five times more likely than GPs to be 
very confident in their skills and physicians in need of additional training on follow-up 
were nearly 2.3 times more likely to be less than very confident in following colorectal 
cancer.  
 
Table 4.11: Final multivariate model showing the relationship between physician-
related variables and physician confidence for following colorectal cancer 
 
Variable 
 
ORadj 95% CI p-value 
Number of follow-up patients    
     Low REF   
     Intermediate 0.604 0.328, 1.113 0.106 
     High 0.274 0.151, 0.497 <0.001 
Specialty    
     General practice REF   
     Specialists 0.192 0.087, 0.422 <0.001 
Need for more training on follow-up care    
     Yes 2.256 1.434, 3.549 <0.001 
     No REF   
 
  4.3.3.3 Lung Cancer 
 Excluding those who said the question was not applicable to them, 35.5% of 
respondents said they were very confident they had the skills to do follow-up for lung 
cancer. This was a mid-range result with respect to the levels of physician confidence 
seen for the most common cancers. Over half (52.8%) of physicians were somewhat 
confident while 8.0% were somewhat unconfident and 3.7% were very unconfident 
(Figure 4.7). 
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Figure 4.7: Physician confidence in following lung cancer (n=377) 
 
 Table 4.12 shows the bivariate associations between physician-related variables 
and the outcome variable, physician confidence in following lung cancer. All variables, 
except years in clinical practice, location of practice and program usefulness were 
retained for further analyses. 
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Table 4.12: Bivariate associations between physician-related variables and physician 
confidence in following lung cancer 
 
Variable, n (%) 
 
OR 95% CI p-value 
Sex    
     Male REF   
     Female 1.719 1.061, 2.784 0.028 
Number of follow-up patients    
     Low REF   
     Intermediate 0.893 0.494, 1.613 0.707 
     High 0.436 0.246, 0.771 0.004 
Specialty    
     General practice REF   
     Specialists 0.488 0.216, 1.103 0.085 
Years in clinical practice    
     0 - 5 yrs REF   
     6 - 10 yrs 0.821 0.288, 2.337 0.711 
     11 - 15 yrs 0.852 0.315, 2.303 0.752 
     16 yrs+ 0.610 0.260, 1.431 0.256 
Years in clinical practice in Saskatchewan    
     0 - 5 yrs REF   
     6 - 10 yrs 0.481 0.240, 0.964 0.039 
     11 - 15 yrs 1.336 0.546, 3.267 0.526 
     16 yrs+ 0.554 0.329, 0.933 0.026 
Number of physicians in primary medical office    
     Solo practice 0.410 0.215, 0.782 0.007 
     Small group practice 0.560 0.307, 1.022 0.059 
     Medium group practice 0.893 0.473, 1.686 0.727 
     Large group practice REF   
Location of practice    
     Metropolitan REF   
     Urban 1.163 0.648, 2.088 0.612 
     Rural 0.890 0.552, 1.434 0.631 
Need for additional patient information    
     Yes 0.571 0.368, 0.888 0.013 
     No REF   
Need for additional clinical information    
     Yes 0.480 0.287, 0.804 0.005 
     No REF   
Need for more training on follow-up care    
     Yes 0.408 0.258, 0.647 <0.001 
     No REF   
Program usefulness    
     Very or somewhat useful 0.004 0.000, 190923.9 0.535 
     Neutral 0.004 0.000, 204685.0 0.538 
     Not very useful or not useful at all REF   
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 Table 4.13 shows the final logistic regression model. The model included number 
of patients on follow-up and the need for more training on follow-up care. Physicians 
with high numbers of FBM patients were significantly more likely to be very confident 
than physicians with a low number of patients. In addition, physicians needing more 
training were 2.4 times more likely to be less than very confident than physicians not 
needing training.  
 
Table 4.13: Final multivariate model showing the relationship between physician-
related variables and physician confidence for following lung cancer 
 
Variable ORadj 95% CI p-value 
Number of follow-up patients    
     Low REF   
     Intermediate 0.847 0.457, 1.567 0.596 
     High 0.438 0.243, 0.790 0.006 
Need for more training on follow-up care    
     Yes 2.378 1.491, 3.791 <0.001 
     No REF   
 
  4.3.3.4 Prostate Cancer 
 Excluding those who said the question was not applicable to them, 44.6% of 
respondents said they were very confident they had the skills to do follow-up for prostate 
cancer. This was a mid-range result compared to physicians’ confidence levels for other 
cancers. Two-fifths (40.2%) of physicians were somewhat confident while 13.1% were 
somewhat unconfident and 2.1% were very unconfident (Figure 4.8). 
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Figure 4.8: Physician confidence in following prostate cancer (n=381) 
 
 
 Table 4.14 shows the bivariate associations between physician-related variables 
and the outcome variable, physician confidence in following prostate cancer. All 
variables were retained for further analyses. 
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Table 4.14: Bivariate associations between physician-related variables and physician 
confidence in following prostate cancer 
 
Variable, n (%) OR 95% CI p-value 
 
 
Sex    
     Male REF   
     Female 3.312 2.037, 5.387 <0.001 
Number of follow-up patients    
     Low REF   
     Intermediate 0.831 0.469, 1.470 0.525 
     High 0.314 0.179, 0.549 <0.001 
Specialty    
     General practice REF   
     Specialists 0.402 0.174, 0.926 0.032 
Years in clinical practice    
     0 - 5 yrs REF   
     6 - 10 yrs 1.989 0.749, 5.279 0.167 
     11 - 15 yrs 1.064 0.439, 2.579 0.891 
     16 yrs+ 0.914 0.432, 1.935 0.815 
Years in clinical practice in Saskatchewan    
     0 - 5 yrs REF   
     6 - 10 yrs 0.470 0.239, 0.923 0.028 
     11 - 15 yrs 0.537 0.247, 1.165 0.116 
     16 yrs+ 0.542 0.330, 0.889 0.015 
Number of physicians in primary medical office    
     Solo practice 0.426 0.228, 0.798 0.008 
     Small group practice 0.649 0.367, 1.147 0.137 
     Medium group practice 0.791 0.441, 1.419 0.432 
     Large group practice REF   
Location of practice    
     Metropolitan REF   
     Urban 1.090 0.624, 1.904 0.761 
     Rural 0.689 0.435, 1.094 0.114 
Need for additional patient information    
     Yes 0.461 0.300, 0.709 <0.001 
     No REF   
Need for additional clinical information    
     Yes 0.401 0.242, 0.663 <0.001 
     No REF   
Need for more training on follow-up care    
     Yes 0.349 0.225, 0.542 <0.001 
     No REF   
Program usefulness    
     Very or somewhat useful 0.199 0.024, 1.667 0.136 
     Neutral 0.334 0.031, 3.579 0.364 
     Not very useful or not useful at all REF   
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 Table 4.15 depicts the final logistic regression model. The model included 
physician sex, number of patients on follow-up and the need for more training of follow-
up care. Female physicians were 2.2 times more likely to be less than very confident in 
following prostate cancer than male physicians. Physicians with high numbers of FBM 
patients were 2.8 times more likely to be very confident than physicians with a low 
number of patients. Physicians needing additional training were 2.6 times more likely to 
be less than very confident than physicians not needing more training.  
 
Table 4.15: Final multivariate model showing the relationship between physician-
related variables and physician confidence for following prostate cancer 
 
Variable 
 
ORadj 95% CI p-value 
Sex    
     Male REF   
     Female 2.161 1.277, 3.657 0.004 
Number of follow-up patients    
     Low REF   
     Intermediate 0.858 0.464, 1.585 0.625 
     High 0.356 0.196, 0.646 0.001 
Need for more training on follow-up care    
     Yes 2.611 1.642, 4.152 <0.001 
     No REF   
 
  4.3.3.5 Gynecological Cancers 
 Excluding those who said the question was not applicable to them, 34.4% of 
respondents said they were very confident they had the skills to do follow-up for 
gynecological cancers. This was in the low to middle range of physician confidence 
levels for the most common cancers. Over half (52.3%) of physicians were somewhat 
confident while 11.0% were somewhat unconfident and 2.3% were very unconfident 
(Figure 4.9). 
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Figure 4.9: Physician confidence in following gynecological cancers (n=392) 
 
 Table 4.16 shows the bivariate associations between physician-related variables 
and the outcome variable, physician confidence in following gynecological cancers. All 
variables, except physician sex, location of practice and the need for additional patient 
information were retained for further analyses, as was program usefulness since the 
overall p-value for the variable was close to the cut-off at p=0.269.  
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Table 4.16: Bivariate associations between physician-related variables and physician 
confidence in following gynecological cancers 
 
Variable, n (%) 
 
OR 95% CI p-value 
Sex    
     Male REF   
     Female 0.784 0.502, 1.225 0.286 
Number of follow-up patients    
     Low REF   
     Intermediate 0.855 0.483, 1.513 0.590 
     High 0.613 0.350, 1.072 0.086 
Specialty    
     General practice REF   
     Specialists 0.134 0.061, 0.293 <0.001 
Years in clinical practice    
     0 - 5 yrs REF   
     6 - 10 yrs 0.723 0.248, 2.110 0.553 
     11 - 15 yrs 0.803 0.288, 2.234 0.803 
     16 yrs+ 0.428 0.179, 1.028 0.058 
Years in clinical practice in Saskatchewan    
     0 - 5 yrs REF   
     6 - 10 yrs 0.401 0.197, 0.815 0.012 
     11 - 15 yrs 0.749 0.318, 1.763 0.508 
     16 yrs+ 0.355 0.206, 0.613 <0.001 
Number of physicians in primary medical 
office 
   
     Solo practice 0.616 0.331, 1.149 0.128 
     Small group practice 0.832 0.463, 1.494 0.537 
     Medium group practice 0.894 0.485, 1.647 0.718 
     Large group practice REF   
Location of practice    
     Metropolitan REF   
     Urban 1.253 0.714, 2.199 0.431 
     Rural 1.168 0.722, 1.889 0.526 
Need for additional patient information    
     Yes 0.788 0.510, 1.219 0.285 
     No REF   
Need for additional clinical information    
     Yes 0.698 0.419, 1.163 0.167 
     No REF   
Need for more training on follow-up care    
     Yes 0.322 0.202, 0.514 <0.001 
     No REF   
Program usefulness    
     Very or somewhat useful 0.362 0.042, 3.128 0.355 
     Neutral 0.867 0.072, 10.423 0.910 
     Not very useful or not useful at all REF   
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 Table 4.17 depicts the final logistic regression model. This model contained the 
highest number of correlates among the cancers: physician specialty, years in clinical 
practice in Saskatchewan, program usefulness and the need for more training of follow-
up care. 
 Specialists were ten times more likely to be confident in following gynecological 
cancers than GPs. Gynecological cancers were the only cancers for which physicians’ 
years in clinical practice in Saskatchewan and perceived program usefulness were 
significant contributors to the regression model. Physicians working 6 to 10 years and 16 
or more years in Saskatchewan were 2.5 times and 2.7 times more likely to be very 
confident in following gynecological cancers, respectively, than physicians practicing in 
the province for only 0 to 5 years. It is unclear why the results for physicians working in 
the province for 11 to 15 years did not follow the same trend. Physicians who saw FBM 
as very or somewhat useful were more 14.7 times more likely to be confident than those 
who said the program was not very useful or not useful at all. As seen before, physicians 
needing additional training were more likely to be less than very confident. In this 
instance, physicians needing additional training were 2.5 times more likely to be less than 
very confident than physicians not needing training. 
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Table 4.17: Final multivariate model showing the relationship between physician-
related variables and physician confidence for following gynecological cancers 
 
Variable 
 
ORadj 95% CI p-value 
Specialty    
     General practice REF   
     Specialists 0.100 0.038, 0.262 <0.001 
Years in clinical practice in Saskatchewan    
     0 - 5 yrs REF   
     6 - 10 yrs 0.402 0.185, 0.873 0.021 
     11 - 15 yrs 1.068 0.399, 2.858 0.896 
     16 yrs+ 0.370 0.203, 0.676 0.001 
Program usefulness    
     Very or somewhat useful 0.068 0.005, 0.884 0.040 
     Neutral 0.233 0.013, 4.318 0.328 
     Not very useful or not useful at all REF   
Need for more training on follow-up care    
     Yes 2.525 1.523, 4.185 <0.001 
     No REF   
   
  4.3.3.6 Lymphomas 
 Excluding those who said the question was not applicable to them, 19.1% of 
respondents said they were very confident they had the skills to do follow-up for 
lymphomas. This was the lowest level of physician confidence seen among the cancers 
asked about in this study. About half (49.5%) of physicians were somewhat confident 
while 26.6% were somewhat unconfident and 4.8% were very unconfident (Figure 4.10). 
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Figure 4.10: Physician confidence in following lymphomas (n=398) 
 
 
 Table 4.18 shows the bivariate associations between physician-related variables 
and the outcome variable, physician confidence in following lymphomas. All variables, 
except program usefulness, were retained for further analyses.       
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Table 4.18: Bivariate associations between physician-related variables and physician 
confidence in following lymphomas 
 
Variable, n (%) 
 
OR 95% CI p-value 
Sex    
     Male REF   
     Female 1.590 0.882, 2.867 0.123 
Number of follow-up patients    
     Low REF   
     Intermediate 0.677 0.315, 1.451 0.315 
     High 0.409 0.198, 0.845 0.016 
Specialty    
     General practice REF   
     Specialists 0.277 0.142, 0.540 <0.001 
Years in clinical practice    
     0 - 5 yrs REF   
     6 - 10 yrs 0.952 0.246, 3.689 0.944 
     11 - 15 yrs 1.000 0.269, 3.718 1.000 
     16 yrs+ 0.482 0.162, 1.429 0.188 
Years in clinical practice in Saskatchewan    
     0 - 5 yrs REF   
     6 - 10 yrs 0.414 0.177, 0.970 0.042 
     11 - 15 yrs 0.700 0.246, 1.994 0.505 
     16 yrs+ 0.430 0.220, 0.839 0.013 
Number of physicians in primary medical 
office 
   
     Solo practice 0.281 0.128, 0.618 0.002 
     Small group practice 0.491 0.227, 1.065 0.072 
     Medium group practice 0.712 0.312, 1.625 0.420 
     Large group practice REF   
Location of practice    
     Metropolitan REF   
     Urban 1.593 0.769, 3.301 0.210 
     Rural 1.026 0.584, 1.802 0.929 
Need for additional patient information    
     Yes 0.498 0.300, 0.827 0.007 
     No REF   
Need for additional clinical information    
     Yes 0.433 0.249, 0.753 0.003 
     No REF   
Need for more training on follow-up care    
     Yes 0.301 0.164, 0.555 <0.001 
     No REF   
Program usefulness    
     Very or somewhat useful 0.708 0.084, 5.969 0.750 
     Neutral 0.467 0.045, 4.896 0.525 
     Not very useful or not useful at all REF   
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 The final regression model for physicians’ confidence in their skills for following 
lymphomas only contained the need for additional training on follow-up care (Table 
4.19). Physicians needing additional training were 3.3 times more likely to be less than 
very confident than those not needing training. 
 
Table 4.19: Final multivariate model showing the relationship between physician-
related variables and physician confidence for following lymphomas 
 
Variable ORadj 95% CI P-value 
Need for more training on follow-up care    
     Yes 3.317 1.803, 6.104 <0.001 
     No REF   
 
 4.3.4 Summary 
 The survey findings revealed community-based physicians’ overall perceptions of 
FBM with 72.3% of respondents finding the program to be very useful as they provide 
follow-up cancer care. The levels of physicians’ information and training needs were also 
described with the greatest need being for additional clinical information. Three 
regression models, all including the variables ‘physician confidence’ and ‘physician 
specialty’, revealed multiple correlates associated with these needs. 
 Percentages of physicians saying they were very confident in following cancers 
ranged from 54.2% for breast cancer to 44.6% for prostate cancer to 44.3% for colorectal 
cancer to 35.5% for lung cancer to 34.4% for gynecological cancers to 19.1% for 
lymphomas. 
 Table 4.20 provides an overview of the significant correlates found in the final 
regression models on physician confidence. The only common correlate among the 
models was the need for additional training. Number of FBM patients was a significant 
correlate in four of the six models and physician specialty was included in half of the 
models.  
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Table 4.20: Significant correlates in final multivariate models regarding physician 
confidence, by cancer type 
 
 Correlates 
Physician 
sex 
Number of 
FBM patients
Physician 
specialty
Years in clinical 
practice in 
Saskatchewan 
Need for 
more 
training 
Program 
usefulness
Cancer Type 
 x x  x  Breast 
 x x  x  Colorectal 
 x   x  Lung 
x x   x  Prostate 
  x x x x Gynecological 
    x  Lymphomas 
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CHAPTER 5 
 
DISCUSSION 
 
 Since the number of cancer patients requiring follow-up care is on the rise, it is 
imperative that physicians are satisfied with FBM and that they are provided with the 
tools required to provide such care. This study’s findings illustrate physicians’ overall 
assessments of FBM as well as their information needs and levels of confidence in 
providing follow-up care. This final chapter provides a discussion of the study’s findings 
and limitations. Recommendations for future study are also considered. 
 
5.1 Participant Characteristics 
 Little is known about the demographic characteristics of physicians providing 
follow-up cancer care in Saskatchewan. Responding physicians, however, could be 
compared against all physicians doing follow-up based on specialty and relative number 
of follow-up patients. Chi-square analyses showed no significant differences between 
respondents and non-respondents based on physician specialty; however, differences 
were found based on the relative number of FBM patients. Responding physicians with 
high numbers of follow-up patients were somewhat overrepresented while those with an 
intermediate number of follow-up patients were marginally overrepresented. Those 
physicians with low numbers of patients were substantially underrepresented at 25.8%, 
compared to 33.5% of all physicians following Saskatchewan cancer patients in the 
community. It may be that physicians with fewer follow-up patients had less of a 
professional interest in FBM and were, thus, less likely to complete the questionnaire. As 
a result, the survey findings may more strongly reflect the views of physicians with 
higher volumes of follow-up patients. 
 Respondents’ overall demographic profile was as follows: a large proportion of 
the respondents were male general practitioners, those who had been in clinical practice 
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for 16 or more years and those who were currently practicing in metropolitan or urban 
settings. 
5.2 Overall Perceptions of FBM 
 This study’s first research question asked, “What are physicians’ overall 
impressions of FBM?” Physicians’ perceptions of the program were overwhelmingly 
positive. The usefulness of the program was rated high with over 90% of respondents 
saying the program was very or somewhat useful. Responses regarding the importance of 
the FBM letter as a reminder were similar. Clearly, community-based physicians consider 
FBM to be important to the delivery of follow-up care. Given these results, it is not 
surprising that the level of satisfaction with the content of the follow-up letter was also 
high.  
 At the same time, however, only one quarter of physicians thought the letters 
were always clear on the timing of tests and procedures to be done during follow-up 
visits, leaving room for improvement. Clinical practice guidelines typically provide this 
type of information on FBM letters but they have only been available for eight types of 
cancer. Physicians have been shown to feel more prepared to accept the responsibility of 
providing follow-up care if they are provided with practice guidelines.13 The guidelines 
serve to compensate for gaps in knowledge and steer physicians toward appropriate 
decision-making.15 Clinical practice guidelines were chosen by over three quarters of 
respondents as the most needed subject of additional clinical information and two fifths 
of physicians needing further training wanted to learn more about the plan for follow-up, 
including the use of clinical practice guidelines. To ensure the timing of follow-up tests 
and procedures is clear to community-based physicians, a review of the clinical practice 
guidelines currently used may be useful. In addition, barring the availability of clinical 
practice guidelines for a particular cancer, other ways of providing clear information, 
such as written recommendations on cancer clinic discharge letters, should be considered. 
5.3 Physicians’ Information Needs 
 The second research question asked whether or not FBM letters give physicians 
enough information to enable them to do cancer follow-up. Responses reflected 
participants’ own subjective assessments of their needs and, thus, were not objective 
appraisals of need. Nevertheless, the three survey questions addressing physicians’ 
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information and training needs revealed high levels of unmet needs with the greatest need 
being seen for additional clinical information. The analyses revealed the necessity to 
provide physicians with more patient and clinical information as well as more training on 
follow-up care. Regression analyses revealed physician-related characteristics associated 
with greater needs for additional support as they provide follow-up care. This information 
may be helpful in tailoring initiatives to help fulfill physicians’ information and training 
needs. 
 5.3.1 Need for Additional Patient Information 
 Nearly three fifths of physicians said they needed additional patient information. 
Since the only patient-specific information FBM letters contain is the patient’s cancer 
type and contact information, this is not surprising. FBM letters, however, are not the 
only documents that go to physicians doing follow-up. Physicians also receive progress 
reports and discharge letters from SCA oncologists containing patient information while 
patients are being seen at a cancer clinic. It would be helpful to do an analysis of these 
letters and their accessibility to physicians as they do follow-up to get a better 
understanding of all the information available to physicians during the follow-up phase of 
care. Through this process gaps in the delivery and processing of patient-specific 
information may also be identified. The type of letter on which each piece of patient 
information should be placed to be the most useful to physicians also needs to be 
investigated. 
 Female physicians were twice as likely to indicate a need for additional patient 
information. Although it is clear that physician characteristics such as sex can impact 
physicians’ information needs, the reason for this finding as it relates to the provision of 
follow-up care is unclear. One other study found that female physicians were more likely 
than male physicians to seek information on patient-specific problems.52 
 Specialists were half as likely to need additional patient information as GPs. The 
reason for this may be that specialists have more in-depth knowledge about caring for 
patients with particular types of cancers; whereas GPs follow any cancers their patients 
develop and generally have less training on follow-up care.  
 Lower physician confidence was associated with a need for additional patient 
information. It is not possible to determine a temporal relationship between these two 
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variables due to the cross-sectional nature of the study; however, this result was as 
expected. Physicians who are not as confident in their skills for following cancers would 
naturally seem to feel a greater need for additional information than those who are more 
confident in their skills. 
 The nature of the interaction effect observed between ‘number of physicians in 
primary medical office’ and ‘location of practice’ was contrary to what was expected 
based on the literature. Similar effect modification was found in the analysis for the 
dependent variable, need for additional clinical information, with few exceptions. 
According to the literature, physician colleagues are often considered a valuable 
information source so it is surprising that in some cases, an increase in the number of 
colleagues in a practice was associated with greater information needs. It was also 
unexpected that rural and metropolitan solo practice physicians would be found to have 
the lowest need for additional patient information.  
 5.3.2 Need for Additional Clinical Information 
 An even greater percentage of physicians indicated a need for additional clinical 
information than patient information. This finding was quite possibly related to the fact 
that only some FBM letters are sent with clinical practice guidelines on them. Rapid 
changes in cancer treatments may also play a role in the existence of these unmet 
information needs.  
 The majority of physicians with needs for additional clinical information wanted 
more clinical practice guidelines, drug information, direction on the timing of bloodwork 
and resources regarding advances in cancer treatments. All of these resources are likely to 
inform the type of follow-up care provided and planning for subsequent follow-up visits. 
In terms of the format of the clinical information needed, physicians placed a high 
importance on printed materials and continuing medical education. These findings may 
reflect the fact that printed materials are still the most accessible to physicians at the point 
of care compared to online resources. The SCA may want to consider making print 
resources available to physicians as well as hosting continuing medical education 
sessions for physicians providing follow-up care. 
 As expected, the final regression analysis revealed that lower physician 
confidence was associated with a need for more clinical information. This finding was 
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consistent with the association found between physician confidence and the need for 
additional patient information.  
 As previously mentioned, the difference in the need for additional clinical 
information among GPs and specialists was greater for female physicians than male 
physicians. This finding should, however, be interpreted with caution due to the large 
confidence intervals seen for sex and specialty which were likely due to the small cell 
sizes seen in a three-way crosstabulation between the need for additional clinical 
information, sex and specialty. The power of the study may not have been sufficient to 
reveal the true relationship between these variables. 
 5.3.3 Physicians’ Training Needs 
 Although the needs for additional training in follow-up cancer care were 
considerably less than those found among British GPs (34.9% compared to 57.5%), 
clearly some training needs of physicians remained unmet.19 The most frequent areas in 
which physicians had training needs related to follow-up care plans and cancer 
treatments. In terms of the delivery method for training, physicians most preferred 
continuing medical education. Given the extent of physicians’ training needs, at the very 
least, opportunities for continuing medical education sessions should be offered on 
follow-up care plans and cancer treatments. 
 Specialists were about one quarter as likely to require additional training as GPs. 
This was as expected since specialists typically receive more extensive training on cancer 
care. Also, cancer follow-up is more likely to be part of specialists’ routine practice. 
 The finding that lower physician confidence was associated with the need for 
additional training is consistent with findings regarding physicians’ needs for additional 
patient and clinical information. In contrast, the regression models for information needs 
were quite different from the model predicting physicians’ training needs. As a result, 
needs for additional patient and clinical information appeared to be more similar 
constructs than training needs and either type of information need.  
 The results of the regression analyses will be useful in the development of 
training sessions for a targeted audience of physicians. For example, perhaps priority 
should be placed on GPs for initial efforts in the provision of additional training. 
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5.4 Physician Confidence in Following Cancers 
 The study’s third research question asked how confident physicians were with 
providing follow-up care. Proportions of physicians saying they were very confident in 
following particular cancers and regression models on physician confidence varied 
widely. Evidently, assessments of physician confidence need to be considered separately 
for each cancer type.  
 Although not studied, other variables that influence levels of physician confidence 
may include the nature of follow-up guidelines, program enrolment patterns, numbers of 
follow-up patients for individual cancers in the province (i.e. survival rates) and the 
extent of physicians’ experiences with following specific cancers. For example, one 
reason for a low level of physician confidence in following lymphomas may be that 
lymphomas are most commonly followed through physicians at the province’s cancer 
clinics and not by community-based physicians. In addition, a lower rate of physician 
confidence was seen for lung cancer than for breast and colorectal cancers. This pattern is 
also seen in the survival rates for these cancers, that is, survival rates for lung cancer are 
much lower than for breast and colorectal cancers.8 As a result, physicians, in general, 
would likely see fewer patients for the follow-up of lung cancer than for breast and 
colorectal cancer giving them less experience with lung cancer follow-up and thus, less 
confidence in following it. These hypotheses, however, cannot be confirmed at this time 
due to a lack of pertinent information. Gynecological cancers were the only cancers for 
which physicians’ years in clinical practice in Saskatchewan was a significant contributor 
to a regression model. This variable was meant to serve as a proxy measure for 
physicians’ experience with FBM; however, it did not capture physicians’ levels of 
experience with following individual cancers. 
 The one common correlate in the six regression models on physician confidence 
was the need for additional training. The fact that physicians in need of additional 
training on follow-up were less confident in their skills for delivering follow-up care was 
as anticipated. Physicians who are not as confident in their skills for following cancers 
would likely feel a greater need for training than those who are more confident in their 
skills. 
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 The variable ‘number of FBM patients’ showed up in several of the regression 
models for physician confidence. Although causation cannot be deduced from the 
findings, it would be reasonable to assume that having more patients and potentially more 
experience in providing follow-up care would positively impact physicians’ levels of 
confidence in delivering such care. 
 Physician specialty was included in half of the regression models. In these cases, 
specialists were significantly more likely to be very confident in their skills for follow-up 
than GPs. This occurrence was not surprising given the more advanced training of 
specialists. It is unclear, however, why this variable was not a significant contributor in 
the other half of the models. 
 The regression model for physician confidence in following prostate cancer was 
the only model on confidence containing physician sex as a correlate. Female physicians 
were more likely to be less than very confident in following prostate cancer than male 
physicians. Although little is known about the effect of physician gender on physician 
confidence, one study suggested that gender differences in the treatment of patients in a 
primary care setting were strongest for genital-specific conditions.53  Interestingly, 
similar results were not seen for breast or gynecological cancers. 
 As already mentioned, gynecological cancers were the only cancers for which 
physicians’ years in clinical practice in Saskatchewan was a significant contributor to the 
regression model. There was no trend, however, in the likelihood of physicians to be very 
confident with increasing years in practice in Saskatchewan. The reason for this was 
unclear. Gynecological cancers were also the only cancers for which perceived program 
usefulness was a significant contributor. Physicians who saw FBM as very or somewhat 
useful were 14.7 times more likely to be confident than those who said the program was 
not very useful or not useful at all. One might think physicians who were less confident 
would be more likely to view the program as useful, perhaps attributing greater 
importance to clinical practice guidelines and FBM letters as reminders, however, this 
was not the case. 
 The regression analyses discussed here revealed a number of variables 
significantly correlating with dependent variables on physician confidence. This 
information may be helpful in devising strategies for increasing physicians’ confidence 
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overall to ensure the delivery of appropriate follow-up care in the province. For example, 
additional training, as it was seen in each of the six regression models on physician 
confidence, may prove useful in raising physicians’ levels of confidence in their skills for 
following various cancers. 
5.5 Study Limitations 
 A number of limitations of this study need to be acknowledged as they are 
important to the interpretation of the data presented in Chapter 4. 
 Respondents may not have been truly representative of the population of 
physicians providing community-based follow-up cancer care in Saskatchewan. 
Comparisons of respondents and non-respondents revealed significant differences based 
on the number of follow-up patients. Despite a good response rate of 52.5%, survey 
findings may not be generalizeable to the total population of physicians participating in 
FBM. A study of mail surveys found an average response rate for physician surveys of 
54%.54 This rate was 13% lower than for surveys of non-physicians. One study of mail 
surveys sent to physicians from 1985 to 1995 discovered an average response rate of 
61%.55 
 The questionnaire’s psychometric properties were not determined; therefore, the 
validity and reliability of the instrument could not be confirmed. This can be problematic; 
however, a number of steps such as consultation with experts and survey pre-testing were 
taken to minimize these concerns.  
 Some physicians also provided written comments that seemed to indicate they 
answered questions using the follow-up done at cancer clinics as their point of reference 
instead of the follow-up done by themselves in their offices. For example, one physician 
wrote that the patient should “follow Cancer Agency advice.” It is unclear how many 
physicians this issue affected. This occurrence was anticipated during the development of 
the survey methodology and it was for this reason that a sample FBM letter was included 
in survey packages. 
 The extent of individual physicians’ experience in following different types of 
cancers was not known. The relative number of FBM patients seen by physicians was not 
necessarily reflective of the depth or breadth of their experience. Experience with follow-
up care may be an important factor in predicting physicians’ information and training 
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needs as well as their levels of confidence in providing follow-up care. In addition, the 
variable ‘years in clinical practice in Saskatchewan’ may or may not have been a suitable 
proxy measure for experience with FBM.  
 It was also not possible to know which physicians had received FBM letters with 
clinical practice guidelines and which had not. This information would likely have been 
useful in interpreting the survey’s results.  
5.6 Conclusions 
 The FBM program is a unique solution to the challenge of increasing numbers of 
cancer patients needing follow-up care. Physicians largely find the program useful to 
their practice yet many require additional information and training to optimize the follow-
up care they provide. Physicians are also less confident in their skills for following some 
cancers than hoped. 
 Some adjustments should be made to the program, such as providing continuing 
medical education for physicians. Regression models for variables related to physicians’ 
information and training needs and levels of confidence in following various cancers will 
be helpful in devising strategies to enhance the capacity of community-based physicians 
to provide optimal follow-up cancer care. 
5.7 Utilization-focused Evaluation 
 This study used a UFE approach and as such, set usefulness and actual use as the 
criteria for judging its success. In these regards, the study was successful. I took 
numerous steps to influence use, such as being sensitive to political and personal factors, 
facilitating decision-making and purposefully planning for use. Although it is not 
possible to determine which of these steps were most important in influencing use, it 
appears that the UFE approach benefited the study.  
 From the project’s beginning, key contacts with the SCA were keen on 
understanding community-based physicians’ views of the program. The SCA approached 
me with a specific need and eagerly awaited the study’s findings. These factors were 
huge assets to the project making the facilitation of use a natural process. The study’s 
findings were particularly important as FBM was in danger of being discontinued. This 
created a sense of urgency for results and indeed preliminary results revealing physicians’ 
high ratings of program usefulness were used to save the program. In addition, survey 
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responses were influential early on in bringing about changes to FBM letters as well as 
cancer clinic progress reports and discharge letters. 
 The largest challenge with the UFE approach was getting feedback from 
evaluation committee members in a timely manner. This challenge was to be expected as 
the group was comprised of busy professionals tasked with many other responsibilities. 
The obstacle was addressed by relying on the input of key contacts at the SCA, when 
necessary, who provided more timely responses. The mere opportunity to provide 
feedback in itself was likely influential in enhancing buy-in among group members. 
 By the time the evaluation report was finalized and delivered to the SCA, many 
findings had already been acted upon. For example, FBM was suspended after the survey 
took place as it did not comply with new privacy legislation. There were questions about 
whether or not the program should be brought back at all. Given the survey findings on 
the program’s usefulness, it was decided that the program must be continued once 
revised. In addition, the findings lent support to the process of standardizing the 
information found on cancer clinic progress reports and discharge letters that had already 
begun. Despite these early actions, the written report was formatted for ease of 
interpretation with such features as charts for the presentation of data and bulleted points 
to summarize main findings. Recommendations were also included which were under the 
control of the intended users and which aimed to facilitate the transition from analysis to 
further action.  
5.8 Future Directions 
 This study investigated views on FBM only from the perspective of the 
community-based physician. Patients’ interactions with the program as well as those of 
cancer clinic physicians would be useful in getting a more complete picture of the impact 
and acceptability of the program among stakeholders. A number of studies addressing 
these other perspectives have been already been planned by the SCA. 
 With respect to community-based physicians, it would be useful to investigate the 
frequency with which important pieces of information are found on progress reports and 
discharge letters as these documents are likely important to fulfilling physicians’ needs 
for information during the follow-up phase of care. Currently, their quality and 
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accessibility to physicians during follow-up is not known. A better understanding of all 
the information provided to physicians is needed. 
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APPENDIX A: Program Logic Model 
 
III. Processing of Completed 
FBM Letters
Physician doing follow-
up completes follow-up 
letter
Issues brought to attention 
of oncologist
Data from follow-up letters 
entered into electronic system
Patient appointment booked 
at cancer clinic
Patient gets needed 
treatment
Patient continues to be 
seen by cancer clinic 
physician for a time
Patient lives longer and/or 
has better quality of life
Patient receives proper 
follow-up care outside 
cancer clinic
 Future follow-up letters 
sent out at revised
 intervals
I. Enrolment of Patients II. FBM Letter Mail-outComponent
Activities
Outcome(s)
Output(s)
Assumptions - Component II
-Appropriate recipient of letter identified and mailing address is 
up-to-date.
-Letter reaches destination.
-Following physician is willing to participate in program.
-Physician has current contact information for patient.
-Physician's staff contacts patient for appointment.
-Patient wants to and is able to go to appointment.
-Appointment is made and patient attends appointment.
-Physician knows what to do for follow-up and provides the 
necessary care.
-Physician has access to information to answer clinical 
questions arising from follow-up.
If suspicion of 
recurrence/metastases, Cancer 
Agency contacted directly
Follow-up letter sent to 
Cancer Agency
YesNo
 Follow-up letter filed in 
patient's chart
Electronic system 
automatically generates 
follow-up letter
Follow-up letter mailed 
to physician following 
patient
Physician does follow-up 
with patient 
Follow-up care provided 
to patient
Issues resolved via phone 
call or other communication 
with patient or physician 
doing follow-up
New cancer cases not 
seen in cancer clinic 
monitored
Discharges from cancer 
clinic monitored
Patient enrolled in 
program
Follow-up letter generated 
for enrollee
Assumptions - Component I
-Health Records receives information on all cancer patients and 
data entry is kept up-to-date.
-Electronic system is properly notified when patients to be enrolled 
in program.
Assumptions - Component III
-Following physician completes letter appropriately.
-Follow-up letter received by Cancer Agency.
-Special issues to be addressed by oncologist are identified by 
Health Records.
-Oncologist addresses issues raised by follow-up letter, phone call 
or fax.
Issues requiring special 
attention?
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APPENDIX B: Key Informant Interview Guide - Oncologists 
 
 
1. What do you see as the purpose of the Follow-By-Mail program? Why do you 
think the SCA started sending FBM letters? 
 
2. What were your first impressions of the program? What are your impressions 
now? Have your impressions changed from when you first encountered the 
program? Why or why not? 
 
3. At what stage or stages do you place patients on FBM? Do you think your 
practices in this area are similar to those of your colleagues at the SCA? 
 
4. Do you inform patients or the referring physician when you put patients on FBM? 
If so, how do you do this? Do you give instructions for follow-up to the 
physicians who will provide the follow-up care? Do you tell the physicians whose 
responsibility it is to ensure the follow-up is done? 
 
5. Do you tell your patients about FBM? What do you tell them? What should FBM 
doctors tell their patients about the program? 
 
6. How much contact have you had with the physicians who are doing follow-up?  
Do you have a sense of what they think of the program? Have physician brought 
up any concerns? Do they seem comfortable with doing follow-up and using 
follow-up guidelines? Have you had any requests from physicians asking for 
assistance or advice regarding follow-up? Can you describe some of those 
situations for me? 
 
7. Are there any areas of knowledge or skills that you think physicians doing follow-
up might be lacking in? Are there any areas where more education or training 
would assist them in providing better follow-up care?  
 
8. Do you think physicians provide adequate follow-up care? Why or why not? Do 
you have any concerns about the care they provide? 
 
9. Do you have any concerns about any negative consequences of the FBM program 
for patients, oncologists or the SCA? 
 
10. What information do FBM physicians get from you about the care their patients 
received at the cancer clinic? When and how often is that information sent to 
them? 
 
11. When do you think the physician should complete the FBM letter? Is one time 
better than another? 
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12. What happens to FBM letters once they are returned to the SCA? What do you 
think should happen to FBM letters once they are returned? 
 
13. Under what circumstances do completed FBM letters get forwarded to you for 
your review? 
 
14. When do you consider a referral to be made using the FBM letter? 
 
15. Do you see any benefits from the FBM program for patients? For oncologists? 
For the SCA? 
 
16. Do you think the FBM program helps improve the quality of care for cancer 
patients? 
 
17. Are there any barriers to putting patients on FBM? Do you think more patients 
should be put on FBM? 
 
18. Is there anything else you think I should know about as I talk to physicians doing 
follow-up and work on developing the questionnaire? 
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APPENDIX C: Key Informant Interview Guide - Community-based Physicians 
 
 
Demographics/General Questions 
 
1. How often do you see cancer patients for follow-up that are on the Cancer 
Agency’s program? 
 
2. How long have you been involved with the program? 
 
3. When would you say patients are placed in the follow-up program? 
 
4. What do you see as the purpose of the follow-up program? 
 
 
First Experiences with FBM & Physician Confidence 
 
5. If you can think back to one of the first times you did follow-up for a patient on 
FBM, what was that like?  How did you feel about doing the follow up? Did you 
have any reservations about it or any questions?  
 
6. Did you know exactly what the Cancer Agency was asking you to do and what 
their expectations were? Has your understanding of this changed at all since then? 
 
7. Who would you say is responsible for a cancer patient’s care after a diagnosis of 
cancer? 
 
8. I want to ask physicians about their levels of confidence when it comes to follow-
up care. Do you have a preference about wording such as using the word 
“confidence” versus “comfortable”? Confidence in doing follow-up may vary 
from patient to patient. Would you be able to answer the question if we asked, “In 
general, how comfortable are you with providing follow-up cancer care?” And 
how would you answer this question yourself?  (If not comfortable) what are the 
reasons for your discomfort? 
 
 
Information Needs 
 
9. Do you feel fully equipped to conduct follow-up with your cancer patients? Why 
or why not? 
 
10. Have you had any oncology training? If so, for how long? When? and Where? 
Have you had the opportunity to attend any oncology courses or meetings as part 
of your Continuing Medical Education? 
 
11. Do you feel that you are up-to-date in your knowledge of follow-up cancer care? 
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12. Do you or have you faced any challenges in providing follow-up care? 
 
 
13. Can you describe a time when you needed some information to answer a question 
that arose from doing follow-up?  What type of information would have or did 
help you? When a question arises during a patient visit, what is your preferred 
source of information? How often would you say you need to seek out 
information from sources other than the follow-up letter and patient reports sent to 
you by the SCA? Is there another time outside of the patient visit when questions 
may arise? 
 
14. Do you feel you need more information or training to do follow-up? If so, are 
your information needs patient-specific or more general? 
 
15. In what areas do you think physicians may require more knowledge and skills to 
provide the necessary follow-up? 
 
16. (If information needs unfulfilled) Why are these information needs not met? 
 
 
Information Provided by and Communication with SCA 
 
17. Do FBM letters give you the necessary information to enable you to do follow-
up? What information is particularly valuable or what is lacking? 
 
18. What do you think about the format of FBM letters? Do you think any additions 
or improvements are needed? 
 
19. Is there any additional patient information that would be helpful for doing follow-
up?  
 
20. Is a mailed letter the best way to communicate with you when it is time for a 
patient’s next follow-up visit? If no, what is a better way? 
 
21. Do you feel the FBM letter serves as a reminder to see your cancer patients? 
 
 
Guidelines for Follow-up 
 
22. Do you use the guidelines provided on the back of the letter?  Are they helpful? 
Why or why not?  
 
23. Do guidelines reflect your current clinical practices? 
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24. Do you require education or more information about using the follow-up 
guidelines? 
 
 
25. Do you have any preference in whether you are sent a general follow-up letter vs. 
a site-specific letter? 
 
Physician Capacity 
 
26. I’m trying to get a sense of physician’s capacities for providing follow-up care, so 
would you be able to see more patients needing follow-up care? What would be a 
manageable number of patients for you to see on this program? If so, what 
additional help would you need from the Cancer Agency? 
 
 
Steps Taken after FBM Letter is Returned  
 
27. If there is evidence of recurrence, metastatic disease or other cancer-related 
problems, what do you think the Cancer Agency does with completed follow-up 
letters returned to them? 
 
28. When should the SCA consider that a referral has been made? 
 
PATIENT-PHYSICIAN COMMUNICATION 
 
29. Do you discuss test results done as part of follow up with your FBM patients? Are 
your FBM patients aware that they are on FBM? How do they come to know they 
are on the program? Do you ever discuss the FBM program with your FBM 
patients? Why or why not? What do you tell your patients about FBM? What are 
some circumstances under which you discuss it? 
 
30. When do you complete FBM letters? Are there any other times? 
 
31. Are there any barriers to completing the letter in a timely manner? 
 
 
PATIENT CARE OUTSIDE OF FBM 
 
32. Do you see your patients in-between FBM letters? Under what circumstances? 
 
33. Do you continue to do follow-up for patients after FBM letters stop coming from 
the SCA? 
 
34. Are there any other ways that the program affects patient care? 
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Additional Comments 
 
35. Do you have any questions about the program? 
 
36. Is there anything else you’d like to mention or something else you think I should 
know as I develop the questionnaire? 
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APPENDIX D: Pre-testing Interview Guide 
 
 
Participant instructions: 
In a minute I’m going to hand you a questionnaire in an envelope and I’d like you to fill 
it out the same way you would if it came to you at your office. I’ll stay in the room while 
you fill it out, but please don’t ask me any questions; just do it as if you were in your 
office and I wasn’t there. I will be taking some notes while you fill out the questionnaire. 
Try not to let this distract you. When you have finished, put the questionnaire into the 
return envelope as if you were mailing it back to the Cancer Agency and then I will ask 
you some questions. Is that clear? 
 
 
Examples of questions based on observation of potential problems: 
I noticed that when you were filling out the survey that…(What goes here depends upon 
what happened in the interview.) 
 
a. Suppose the respondent skipped an item...“I’d like to ask about this item 
(pointing to it). I see that you left it blank. Was there a particular reason for 
that?” 
 
b. Suppose the respondent frowned… “I noticed here that you seemed to be 
thinking really hard, or was there something about this question you were trying 
to figure out?” 
 
c. Suppose the respondent scanned ahead…“I noticed that when you got here you 
stopped for a minute, looked ahead and turned the survey over. Could you tell me 
what you might have been thinking about here?” 
 
 
General Questions asked at the end of Interviews: 
 
a. Overall, what was your impression of the mailing package? 
 
b. Was the content of the cover letter clear and easy to understand? Did the cover 
letter raise any concerns for you that were not adequately addressed? Do you feel 
that your privacy will be protected? 
 
c. Was there any confusion regarding why the follow-up letter was included in the 
survey package? 
 
d. On a scale of 1 to 5, where 1 means very easy and 5 means very difficult, how 
easy or difficult was it for you to figure out where to begin on the survey? 
 
e. Was the survey easy to read? Were any parts confusing? 
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f. Was the meaning of any word unclear? 
 
g. Were all technical terms used appropriately? 
 
h. Were some questions more difficult to answer than others? 
 
i. Were any questions lacking the appropriate response options? 
 
j. Were there any questions where some response options could be eliminated? 
 
k. Do you have any suggestions regarding the addition or deletion of questions, 
clarification of instructions or improvements in format? 
 
l. Do you have anything else you would like to tell me that you haven’t had a 
chance to mention? 
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APPENDIX E: Pre-testing Cover Letter 
 
May 6, 2005 
 
Please use the postage paid 
envelope and mail the completed 
survey to: 
 
Raegan Osicki 
Saskatoon Cancer Centre 
20 Campus Drive 
Saskatoon, SK   S7N 4H4 
Dr. «firstname» «lastname» 
«address1» 
«address2» 
«city», «province»  «postcode» 
 
Dear Dr. «lastname»: 
 
RE:  Follow-up of Cancer Patients  
 
I invite your participation in an evaluation of the Saskatchewan Cancer Agency’s (SCA) 
Follow by Mail (FBM) program. The FBM program is intended to assist physicians in the 
follow-up of cancer patients who have completed treatment. FBM suggests follow-up 
procedures and provides a mechanism for reporting information back to the cancer clinics 
about the disease status of patients. The enclosed survey will collect valuable feedback from 
physicians about the FBM program, as we strive to improve the quality of cancer care. 
 
We are contacting all physicians currently doing cancer follow-up to ask them about their 
information needs, their confidence in conducting cancer follow-up and procedures for 
referring patients back to a Cancer Centre. Results from the survey will assist the SCA in 
tailoring the FBM program to meet the needs of the physicians involved. Your feedback will 
enhance the delivery of appropriate and timely patient care. 
 
Please complete the enclosed questionnaire by May 20, 2005. It takes about 20 minutes to 
complete. This survey is voluntary; however, because your involvement is an integral part of 
the follow-up of cancer patients, your input is vital for further development of this program. 
There are no known risks to participating and you may skip any questions that you do not 
wish to answer. Your answers are completely confidential and will be released only in 
aggregate form, meaning no individual’s answers will be identified. The study is being 
carried out by external researchers (Raegan Osicki & Kathryn Green, University of 
Saskatchewan, 306-966-7839) as an added measure to ensure confidentiality. The 4-digit 
number on the return envelope will be used only to remove respondents’ names from mailing 
lists for subsequent correspondence. This evaluation has been approved by the University of 
Saskatchewan Behavioural Research Ethics Board (Beh #05-56). By returning the survey, 
you are giving your consent to participate. 
 
Thank you in advance for participating in this important project. Questions regarding your 
rights as a participant may be addressed by calling the Office of Research Services (306-966-
2084). You may call collect. If you have any questions about this survey or you would like a 
summary of the study’s results, please contact Jon Tonita (306-766-2173, 
jon.tonita@scf.sk.ca). 
 
Sincerely, 
 
 
 
 
Dr. D. R. Popkin 
Executive Director, Saskatoon Cancer Centre
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APPENDIX F: Draft Questionnaire Used for Pre-testing 
 
 
Instructions:  Please place an X beside the one option that best answers each 
question below unless otherwise indicated. 
 
 
Section A: Follow-Up Letters 
This section asks about your views on the follow-up letters that the Cancer Agency sends 
you for each of your cancer patients in the follow-up phase of care. 
 
 
1.   In general, is it clear what type of cancer you are being asked to follow when you 
receive a follow-up letter? 
 
 Yes, always 
 Yes, sometimes 
 No 
 
2.   How important a role does the follow-up letter play in reminding you when it is 
time to see your cancer patients for follow-up?  
 
 Very important 
 Somewhat important 
 Neither important nor unimportant 
 Somewhat unimportant 
 Very unimportant 
     
3.   How important is it to receive clinical practice guidelines with follow-up letters? 
 
 Very important 
 Somewhat important 
 Neither important nor unimportant 
 Somewhat unimportant 
 Very unimportant 
 
 
4.   Are follow-up letters clear about the timing of tests and procedures to be done as 
part of follow-up? 
 
 Always 
 Usually 
 Sometimes 
 Rarely 
 Never          
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5.   How satisfied are you with the content of the follow-up letters (e.g., patient 
information, items needing responses, response options)? 
 
 Very satisfied 
 Somewhat satisfied 
 Neither satisfied nor dissatisfied 
 Somewhat dissatisfied 
 Very dissatisfied 
 Not sure    
                  (If dissatisfied) What should be changed,  
                                                                          added or omitted? 
 
 
 
 
Section B: Information Provided by Cancer Clinic Physicians 
This section asks about your views on the information provided to you by cancer clinic 
physicians, as such information may impact physician practices during follow-up care. 
 
 
6.   In the progress reports sent to you by the cancer clinic, are the treatments your 
patients have received made clear?  
 
 Always 
 Usually 
 Sometimes 
 Rarely 
 Never 
 Not applicable 
 
 
7.   In the progress reports sent to you by the cancer clinic, do you feel that the side 
effects or complications your cancer patients have experienced during treatment are 
made clear? 
 
 Always 
 Usually 
 Sometimes 
 Rarely 
 Never 
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 8.   How frequently do discharge letters from the cancer clinic include clear 
recommendations about the tests and examinations your cancer patients will need to 
have done over the course of long-term follow-up care? 
 
 Always 
 Usually 
 Sometimes 
 Rarely 
 Never 
 
 
 
Section C: Levels of Confidence Regarding the Provision of Follow-Up Care 
 
 
9.    In general, how confident are you that you have the skills needed to provide 
appropriate follow-up care for patients with histories of the cancers listed below? 
 
 
Breast 
 
Very 
confident 
 
 
Very 
confident 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Colorectal 
 
 
 
Very 
confident 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Lung 
 
 
Very 
confident 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Prostate 
 
 
Very 
confident 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Gynecological 
 
 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Lymphomas Very 
confident 
 
 
Somewhat 
confident 
 
Somewhat 
unconfident 
Very 
unconfident 
Not 
applicable 
   
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10.    In general, how comfortable are you with conducting follow-up care for 
patients with histories of the cancers listed below? 
 
 
Breast 
 
Very 
comfortable 
 
 
Somewhat 
comfortable
 
Somewhat 
uncomfortable
 
Very 
uncomfortable 
 
Not 
applicable
 
Colorectal 
 
Very 
comfortable 
 
 
Very 
comfortable 
Somewhat 
comfortable
 
Somewhat 
uncomfortable
 
Very 
uncomfortable 
 
Not 
applicable
 
Lung 
 
 
Very 
comfortable 
Somewhat 
comfortable
 
Somewhat 
uncomfortable
 
Very 
uncomfortable 
 
Not 
applicable
 
Prostate 
 
 
Very 
comfortable 
Somewhat 
comfortable
 
Somewhat 
uncomfortable
 
Very 
uncomfortable 
 
Not 
applicable
 
Gynecological 
 
 
Very 
comfortable 
Somewhat 
comfortable
 
Somewhat 
uncomfortable
 
Very 
uncomfortable 
 
Not 
applicable
 
Lymphomas 
 
 
Somewhat 
comfortable
 
Somewhat 
uncomfortable
Very 
uncomfortable 
Not 
applicable
   
 
 
 
 
 
Section D: Information Needs 
 
 
11.  Do you need any additional patient information from the Cancer Agency to do 
follow-up? 
 
 Yes 
 No 
                     (If Yes) What additional information is needed?  
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12.   Is there any clinical information related to follow-up, in addition to the 
information you already receive from the cancer clinic, that would help improve 
your practice?  
 
 Yes 
 No 
 (If Yes) Rank the following subject areas in terms their 
importance to meeting your information needs, with “1” as 
the most important, “2” as the 2nd most important and so 
on. 
____Drug information 
____Advances in cancer treatments 
____Managing the psychosocial needs of patients 
____Timing of blood work 
____Clinical practice guidelines 
____Other—specify:_________________________ 
 
 
 (If Yes) Rank the following based on their usefulness in 
providing clinical information, with “1” as the most useful, 
“2” as the 2nd most useful and so on. 
       ____Continuing medical education 
        ____Printed materials 
       ____Online resources 
       ____Resource person 
       ____Other—specify:_______________________ 
 
 
 
 
13.   Do you feel that you require more training on follow-up cancer care?  
 
 Yes 
 No 
              (If Yes) What type of training is needed and what 
              would be the best way to deliver it? 
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14.  How do you go about answering your own clinically-based questions that arise 
during follow-up visits? 
 
 
 
 
 
 
Section E:  Follow-Up Practices 
 
 
15.  Who do you believe has the primary responsibility to ensure that cancer patients 
get appointments for follow-up care? 
 
 Patients (and/or their families) 
 Physicians who are doing follow-up 
 Cancer Agency 
 Other – specify:_________________________ 
 
 
16.  Do you discuss the follow-up program with your patients?  
 
 Yes, always 
 Yes, sometimes 
 No 
                                                             (If Yes) What do you tell them? 
 
 
 
 
 
17.   Which one of the following statements best describes how follow-up 
appointments are booked for your cancer patients? 
 
 Someone from my office calls the patients 
 Patients call my office when it is time for a follow-up visit 
 Patients usually have appointments for other medical needs booked 
already so follow-up care is provided during those visits 
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18.   Do you ever encounter barriers to completing follow-up letters in a timely 
manner? 
 
 Yes 
 No 
                                (If Yes) What are the barriers? Choose all that apply. 
 
 It is not always possible to contact the patient. 
 The patient is not always willing or able to come to a 
follow-up visit. 
 It is difficult to book patient appointments within a 
short period of time. 
 Other—specify:_________________________ 
 
 
19.   When you want to refer a patient who is on follow-up to a cancer clinic, do you 
use the follow-up letter as a referral? 
 
 Yes, always 
 Yes, sometimes 
 No, never 
 No, I haven’t had to refer 
  a patient back to the 
   cancer clinic. 
                                       (If Yes) How do you indicate that you 
                                                                        wish to make a referral? 
 
 
 
 
 
20.   If you indicate on the follow-up letter that one of your patients is exhibiting 
signs of recurrence or metastases, what do you think the Cancer Agency does with 
the follow-up letter? 
 
 The letter is treated as a referral 
 The comments are reviewed by an oncologist to determine a suitable 
course of action 
 The letter is filed in the patient’s chart  
 Other—specify:_________________________ 
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21.   Referring to Question 20, what do you think should happen with these follow-
up letters? 
 
 
 
 
 
 
22.   Do you ever see patients for cancer follow-up more frequently than suggested 
by the follow-up letters? 
 
 Yes 
 No 
                                (If Yes) Under what circumstances do you see patients 
                                           more frequently? 
 
 
 
 
 
23.   Do you continue to do follow-up for cancer patients after follow-up letters stop 
coming from the Cancer Agency? 
 
 Yes, always 
 Yes, sometimes 
 No 
 
 
24.   On the whole, how useful is the follow-up program to you in providing cancer 
patient follow-up? 
 
 Very useful 
 Somewhat useful 
 Neutral 
 Somewhat unuseful 
 Very unuseful 
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Section F: Background Information 
Your answers to the questions in this section will help us to determine if there are any 
differences in the views of physicians with various backgrounds. 
 
 
25.   What is your gender? 
 
 Male 
 Female  
 
 
26.   For how many years have you worked in clinical practice? 
 
 0-5 years 
 6-10 years 
 11-15 years 
 Greater than 15 years 
 
 
27.  For how many years have you worked in clinical practice in Saskatchewan? 
 
 0-5 years 
 6-10 years 
 11-15 years 
 Greater than 15 years 
 
 
28.   What is your medical specialty? 
 
 General practice/Family practice 
 Other specialty 
 
 
29.   Do you directly provide cancer treatments for patients? 
 
 Yes 
 No 
 
 
30.   Including yourself, how many clinicians work in your primary medical 
practice?  
 
       Number of physicians:   _____   
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31.   Which of the following best describes the region in which your primary medical 
practice is located? 
 
 Saskatoon or Regina 
 A city of 10,000 or more residents, other than Saskatoon or Regina 
 A city, town, village or hamlet with fewer than 10,000 residents 
 
 
32.   Is your primary medical practice in the Mamawetan Churchill River, Keewatin 
Yatthé or Athabasca Health Region? 
 
 Yes 
 No 
 
 
31.  Additional Comments:  
If you would like to make any additional comments about the survey, the follow-up 
program or any other related matter, please do so in the space provided below. You may 
attach additional pages if needed. 
 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
 
Thank you for your participation!
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APPENDIX G: First Mailing’s Cover Letter 
 
 
 
June 13, 2005 
 Please use the postage paid 
envelope and mail the completed 
survey to: 
 
Raegan Osicki 
Saskatoon Cancer Centre 
20 Campus Drive 
Saskatoon, SK   S7N 4H4 
Dr. «firstname» «lastname» 
«address1» 
«address2» 
«address3» 
«address4» 
«city», SK  «postcode» 
 
Dear Dr. «lastname»: 
 
RE:  Follow-up of Cancer Patients  
 
I invite your participation in an evaluation of the Saskatchewan Cancer Agency’s (SCA) Follow-
By-Mail (FBM) program. The FBM program is intended to assist physicians in the follow-up of 
cancer patients who have completed treatment. FBM suggests follow-up procedures and provides 
a mechanism for reporting the disease status of patients to the cancer clinics. The enclosed survey 
will provide valuable feedback from physicians about the program, as we strive to improve the 
quality of cancer care. 
 
Please fill out the enclosed questionnaire by June 27, 2005. It takes about 15 minutes to 
complete. The survey is voluntary and your answers are completely confidential. There are no 
known risks to participating and you may skip any questions you do not wish to answer. The 
study is being carried out by external researchers (Raegan Osicki & Dr. Kathryn Green, 
University of Saskatchewan, 306-966-7839) as an added measure to ensure confidentiality. The 
4-digit number on the return envelope will be used to remove respondents’ names from mailing 
lists for subsequent correspondence. The file linking participants’ names to their 4-digit codes 
will be destroyed after the last mailing has been sent. This evaluation has been approved by the 
University of Saskatchewan Behavioural Research Ethics Board (Beh #05-56). By returning the 
survey, you are giving your consent to participate.  
 
Thank you in advance for participating in this important project. Questions regarding 
participants’ rights may be addressed by calling the Office of Research Services (306-966-2084). 
You may call collect. If you have any questions about this survey or you would like a summary of 
the study’s results, please contact Jon Tonita (306-766-2173, jon.tonita@scf.sk.ca). 
 
Sincerely, 
 
Dr. D. R. Popkin 
Executive Director, Saskatoon Cancer Centre 
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APPENDIX H: Reminder/Thank you Letter 
 
 
 
June 20, 2005 
 
Dr. «firstname» «lastname» 
«address1» 
«address2» 
«address3» 
«address4» 
«city», SK  «postcode» 
 
Dear Dr. «lastname»: 
 
RE: Reminder to Give Your Input 
 
In the last week a questionnaire was sent to you seeking your views on the Saskatchewan 
Cancer Agency’s follow-up cancer care program.   
 
If you have already completed and returned the questionnaire, please accept our sincere 
thanks. If not, please do so today. We are especially grateful for your help because it is 
only through hearing your opinions and understanding your experiences of follow-up that 
we can tailor our program to meet your needs. 
 
If you did not receive a questionnaire, or if it has been misplaced, please contact Jon 
Tonita (306-766-2173, jon.tonita@scf.sk.ca) and we will get another one in the mail to you 
today. Thank you for your participation in this important project. 
 
Sincerely, 
 
Dr. D. R. Popkin 
Executive Director, Saskatoon Cancer Centre 
  
Please use the postage paid envelope you 
received earlier and mail the completed 
survey to: 
 
Raegan Osicki 
Saskatoon Cancer Centre 
20 Campus Drive 
Saskatoon, SK   S7N 4H4 
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APPENDIX I: Third Mailing’s Cover Letter 
 
 
 
July 4, 2005 
 
Dr. «firstname» «lastname» 
«address» 
«city», SK  «postcode» 
 
Dear Dr. «lastname»: 
 
RE:  Last chance for input about our Follow-By-Mail program 
 
About 3 weeks ago we sent you a questionnaire that asked about your experiences with 
our community cancer follow-up program. We would still like to hear from you. If 
you’ve already responded, thank you for your participation and you can discard the 
enclosed questionnaire. 
 
This study will assist the Cancer Agency to tailor its follow-up program to meet 
physicians’ needs as they provide follow-up cancer care. Your feedback will therefore 
help us improve the delivery of appropriate, consistent and timely patient care. 
 
We hope that you will fill out and return the questionnaire soon so that your responses 
can be included in our analyses. It takes about 15 minutes to complete. The survey is 
voluntary and confidential. There are no known risks to participating in this project and 
you may skip any questions that you do not wish to answer. The study is being carried 
out by external researchers (Raegan Osicki & Dr. Kathryn Green, University of 
Saskatchewan, 306-966-7839) as an added measure to ensure confidentiality and it has 
been approved on ethical grounds by the University of Saskatchewan Behavioural 
Research Ethics Board (Beh #05-56). Consent to participate is implied with the return of 
the survey. 
 
Questions regarding your rights as a participant may be addressed by calling the Office of 
Research Services (Ph.306-966-2084). You may call collect. If you have any other 
questions, you can contact Jon Tonita (Ph.306-766-2173, jon.tonita@scf.sk.ca ). 
 
 
Sincerely, 
 
Dr. D. R. Popkin 
Executive Director, Saskatoon Cancer Centre 
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APPENDIX J: Questionnaire (final version) 
 
 
Instructions:  Please place an X beside the one option that best answers each 
question below unless otherwise indicated. 
 
 
Section A: Follow-Up Letters 
This section asks about your views on the follow-up letters that the Cancer Agency sends 
you for each of your cancer patients in the follow-up phase of care. 
 
 
1.   In general, is it clear what type of cancer you are being asked to follow when you 
receive a follow-up letter? 
 
 Yes, always 
 Yes, sometimes 
 No 
 
2.   How important a role does the follow-up letter play in reminding you when it is 
time to see your cancer patients for follow-up?  
 
 Very important 
 Somewhat important 
 Neither important nor unimportant 
 Somewhat unimportant 
 Very unimportant 
     
3.   How important is it to receive clinical practice guidelines with follow-up letters? 
 
 Very important 
 Somewhat important 
 Neither important nor unimportant 
 Somewhat unimportant 
 Very unimportant 
 
 
4.   Are follow-up letters clear about the timing of tests and procedures to be done as 
part of follow-up? 
 
 Always 
 Usually 
 Sometimes 
 Rarely 
 Never          
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5.   How satisfied are you with the content of the follow-up letters (e.g., patient 
information, items needing responses, response options)? 
 
 Very satisfied 
 Somewhat satisfied 
 Neither satisfied nor dissatisfied 
 Somewhat dissatisfied 
 Very dissatisfied 
 Not sure    
                  (If dissatisfied) What should be changed,  
                                                                          added or omitted? 
 
 
 
 
Section B: Information Provided by Cancer Clinic Physicians 
This section asks about your views on the information provided to you by cancer clinic 
physicians, as such information may impact physician practices during follow-up care. 
 
 
6.   In the progress reports sent to you by the cancer clinic, are the treatments your 
patients have received made clear?  
 
 Always 
 Usually 
 Sometimes 
 Rarely 
 Never 
 Not applicable 
 
 
7.   In the progress reports sent to you by the cancer clinic, do you feel that the side 
effects or complications your cancer patients have experienced during treatment are 
made clear? 
 
 Always 
 Usually 
 Sometimes 
 Rarely 
 Never 
 Not applicable 
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 8.   How frequently do discharge letters from the cancer clinic include clear 
recommendations about the tests and examinations your cancer patients will need to 
have done over the course of long-term follow-up care? 
 
 Always 
 Usually 
 Sometimes 
 Rarely 
 Never 
 Not applicable 
 
 
Section C: Levels of Confidence Regarding the Provision of Follow-Up Care 
 
 
9.    In general, how confident are you that you have the skills needed to provide 
appropriate follow-up care for patients with histories of the cancers listed below? 
 
 
Breast 
 
Very 
confident 
 
 
Very 
confident 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Colorectal 
 
 
 
Very 
confident 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Lung 
 
 
Very 
confident 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Prostate 
 
 
Very 
confident 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Gynecological 
 
 
Somewhat 
confident 
 
Somewhat 
unconfident 
 
Very 
unconfident 
 
Not 
applicable 
 
Lymphomas Very 
confident 
 
 
Somewhat 
confident 
 
Somewhat 
unconfident 
Very 
unconfident 
Not 
applicable 
   
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Section D: Information Needs 
 
 
10.  Do you need any additional patient information from the Cancer Agency to do 
follow-up? 
 
 Yes 
 No 
                     (If Yes) What additional information is needed?  
          Choose all that apply. 
 
 Prognosis 
 Cancer type 
 Last known cancer status 
 Other – specify:_________________________ 
 
 
11.   Is there any clinical information related to follow-up, in addition to the 
information you already receive from the cancer clinic, that would help improve 
your practice?  
 
 Yes 
 No 
 (If Yes) RANK the following subject areas in terms their 
importance to meeting your information needs, with “1” as 
the most important, “2” as the 2nd most important and so 
on. 
____Drug information 
____Advances in cancer treatments 
____Managing the psychosocial needs of patients 
____Timing of blood work 
____Clinical practice guidelines 
____Other—specify:_________________________ 
 
 
 (If Yes) RANK the following based on their usefulness in 
providing clinical information, with “1” as the most useful, 
“2” as the 2nd most useful and so on. 
       ____Continuing medical education 
        ____Printed materials 
       ____Online resources 
       ____Resource person 
       ____Other—specify:_______________________ 
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12.   Do you feel that you require more training on follow-up cancer care?  
 
 Yes 
 No 
              (If Yes) What type of training is needed and what 
              would be the best way to deliver it? 
 
 
 
 
 
13.  How do you go about answering your own clinically-based questions that arise 
during follow-up visits? 
 
 
 
 
 
 
Section E:  Follow-Up Practices 
 
 
14.  Who do you believe has the primary responsibility to ensure that cancer patients 
get routine appointments for follow-up care? 
 
 Patients (and/or their families) 
 Physicians who are doing follow-up 
 Cancer Agency 
 Other – specify:_________________________ 
 
 
15.  Do you discuss the follow-up program with your patients?  
 
 Yes, always 
 Yes, sometimes 
 No 
                                                             (If Yes) What do you tell them? 
 
 
 
 
 
 
 
 
 107
 
16.   Which one of the following statements best describes how follow-up 
appointments are booked for your cancer patients? 
 
 Someone from my office calls the patients 
 Patients call my office when it is time for a follow-up visit 
 Patients usually have appointments for other medical needs booked 
already so follow-up care is provided during those visits 
 
 
17.   Do you ever encounter barriers to completing follow-up letters in a timely 
manner? 
 
 Yes 
 No 
                                (If Yes) What are the barriers? Choose all that apply. 
 
 It is not always possible to contact the patient. 
 The patient is not always willing or able to come to a 
follow-up visit. 
 It is difficult to book patient appointments within a 
short period of time. 
 Other—specify:_________________________ 
 
 
18.   Do you use the follow-up letter as a referral when you want to refer a follow-up 
patient to a cancer clinic? 
 
 Yes, always 
 Yes, sometimes 
 No, never 
 No, I haven’t had to refer 
  a patient back to the 
   cancer clinic. 
                                       (If Yes) How do you indicate that you 
                                                                            wish to make a referral? 
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19.   What do you think the Cancer Agency does with the follow-up letter if you 
indicate a patient is exhibiting signs of recurrence or metastases? 
 
 The letter is treated as a referral 
 The comments are reviewed by an oncologist to determine a suitable 
course of action 
 The letter is filed in the patient’s chart  
 Other—specify:_________________________ 
 
 
20.   Referring to Question 19, what do you think should happen with these follow-
up letters? 
 
 
 
 
 
 
21.   Do you ever see patients for cancer follow-up more frequently than suggested 
by the follow-up letters? 
 
 Yes 
 No 
                                (If Yes) Under what circumstances do you see patients 
                                           more frequently? 
 
 
 
 
 
22.   Do you continue to do follow-up for cancer patients after follow-up letters stop 
coming from the Cancer Agency? 
 
 Yes, always 
 Yes, sometimes 
 No 
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23.   On the whole, how useful is the follow-up program to you in providing cancer 
patient follow-up? 
 
 Very useful 
 Somewhat useful 
 Neutral 
 Not very useful 
 Not useful at all 
 
 
 
Section F: Background Information 
Your answers to the questions in this section will help us to determine if there are any 
differences in the views of physicians with various backgrounds. 
 
 
24.   What is your gender? 
 
 Male 
 Female  
 
 
25.   For how many years have you worked in clinical practice? 
 
 0-5 years 
 6-10 years 
 11-15 years 
 Greater than 15 years 
 
 
26.  For how many years have you worked in clinical practice in Saskatchewan? 
 
 0-5 years 
 6-10 years 
 11-15 years 
 Greater than 15 years 
 
 
27.   What is your medical specialty? 
 
 General practice/Family practice 
 Other specialty 
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28.   Including yourself, how many clinicians work in your primary medical 
practice?  
 
       Number of physicians:   _____   
 
 
29.   Which of the following best describes the region in which your primary medical 
practice is located? 
 
 Saskatoon or Regina 
 A city of 10,000 or more residents, other than Saskatoon or Regina 
 A city, town, village or hamlet with fewer than 10,000 residents 
 
 
30.   Is your primary medical practice in the Mamawetan Churchill River, Keewatin 
Yatthé or Athabasca Health Region? 
 
 Yes 
 No 
 
 
31.  Additional Comments:  
If you would like to make any additional comments about the survey, the follow-up 
program or any other related matter, please do so in the space provided below. You may 
attach additional pages if needed. 
 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
Thank you for your participation!
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APPENDIX K: Ethics Approval Letter 
 
 
UNIVERSITY OF SASKATCHEWAN 
BEHAVIOURAL RESEARCH ETHICS BOARD 
http://www.usask.ca/research/ethics.shtml 
 
NAME: Kathryn Green (Reagan Osicki)   Beh #05-56 
 Community Health and Epidemiology     
 
DATE: April 27th, 2005 
 
The University of Saskatchewan Behavioural Research Ethics Board has reviewed the 
Application for Ethics Approval for your research study “A Survey of Physicians’ Views on the 
Saskatchewan Cancer Agency’s Follow-By-Mail Program” (Beh #05-56).  Thank you for making 
the requested modifications. 
 
1. Your study has been APPROVED. 
 
2. Any significant changes to your proposed method, or your consent and 
recruitment procedures should be reported to the Chair for Research Ethics Board 
consideration in advance of its implementation. 
 
3. The term of this approval is for 5 years. 
 
4. This approval is valid for one year. A status report form must be submitted 
annually to the Chair of the Research Ethics Board in order to extend approval.  This 
certificate will automatically be invalidated if a status report form is not received 
within one month of the anniversary date.  Please refer to the website for further 
instructions http://www.usask.ca/research/behavrsc.shtml 
 
 
 
 
 
 
I wish you a successful and informative study. 
 
 
 
_______________________________ 
Dr. Valerie Thompson, Chair  
University of Saskatchewan 
Behavioural Research Ethics Board  
 
VT/cc
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APPENDIX L: Analysis of Qualitative Comments – Content of Additional Training 
 
 
Physicians indicating that they needed more training on follow-up care were asked to 
indicate the type of training needed. Ninety-three comments contained information 
pertaining to the subject areas physicians would like training in.   
 
Follow-up Plan (40, 43.0%) 
• Clinical practice guidelines/protocols for follow-up (21) 
• Follow-up in general (10) 
• Clear plan of what the physician was expected to do (4) 
• Timing of bloodwork (4) 
• Investigation for clinical metastasis (1) 
 
Cancer Treatments (20, 21.5%) 
• Advances in Cancer Treatments/Current Treatments (18) 
• How decisions are made about treatment choices (1) 
• Chemotherapy protocols (1) 
 
Pharmaceuticals (10, 10.8%) 
• Information on new and existing drugs (7) 
• Managing side effects (2) 
• Prescriptions for clinical metastasis (1) 
 
Managing Patients’ Psychosocial Needs (6, 6.5%) 
 
Palliative Care (4, 4.3%) 
 
Other Subject Areas (13, 14.0%) 
• Included pain control, expected prognosis for various cancers, increased 
awareness of websites, basic science, tumor markers, discussions of case 
studies, early detection and screening, local clinical trials, proper completion 
of follow-up letter, justification of the clinical guidelines used and improving 
the information provided by the cancer clinic. 
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APPENDIX M: Analysis of Qualitative Comments – Format for Additional 
Training 
 
 
Physicians indicating that they needed more training on follow-up care were asked to 
indicate the best way to deliver further training. Comments were included in more than 
one major grouping where appropriate. A total of 145 comments were analyzed for 
suggestions on the format of training sessions. Eleven specialists and 133 GPs gave 
comments. 
 
Comments related to CME (68, 46.8%) 
• CME – no further description (46) 
• CME meetings/seminars (15) 
• CME conference (3) 
• CME course (1) 
• Online CME (1) 
• Office-based CME (1) 
• CME Group discussions (1) 
 
Comments related to seminars/lectures (23, 15.9%) 
• CME meetings/seminars (15) 
• Seminars/Lectures - no further description (7) 
• Case-based lectures (1) 
 
Comments related to online training (20, 13.8%) 
• Online materials/information (11) 
• Online courses (5) 
• Online - no further description (3) 
• Online CME (1) 
 
Comments related to printed materials (18, 12.4%) 
• Printed materials – no further description (13) 
• Regular newsletter (2) 
• Binder with follow up care for each type of cancer (1) 
• More explicit information on follow up letter (1) 
• Journals (1) 
 
Comments related to courses (12, 8.3%) 
• Online courses (3) 
• Refresher courses (3) 
• Workshop (2) 
• CME course (1) 
• Basic courses (1) 
• Weekend course (1) 
• 1-2 day program (1) 
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Comments related to conferences (10, 6.9%) 
• Conference - no further description (7) 
• CME conference (3) 
 
Comments related to other formats (17, 11.7%)  
• Included telehealth, telemedicine, teleconferencing, small group sessions, time 
in the cancer clinic, meetings, access to a resource person at a cancer clinic, 
resources at the cancer clinic, training at a local place, hospital rounds, multi-
specialty consensus meetings and meetings with an oncologist. 
 
An additional 28 comments offered no information relevant to the question.  
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